Activation	O
of	O
the	O
granulocyte-macrophage	B-DNA
colony-stimulating	I-DNA
factor	I-DNA
promoter	I-DNA
in	O
T	B-cell_type
cells	I-cell_type
requires	O
cooperative	O
binding	O
of	O
Elf-1	B-protein
and	O
AP-1	B-protein
transcription	B-protein
factors	I-protein
.	O

The	O
granulocyte-macrophage	B-DNA
colony-stimulating	I-DNA
factor	I-DNA
(	I-DNA
GM-CSF	I-DNA
)	I-DNA
gene	I-DNA
has	O
been	O
studied	O
extensively	O
as	O
a	O
model	O
system	O
of	O
transcriptional	O
induction	O
during	O
T-lymphocyte	O
activation	O
.	O

The	O
GM-CSF	B-DNA
gene	I-DNA
is	O
not	O
expressed	O
in	O
resting	B-cell_type
peripheral	I-cell_type
blood	I-cell_type
T	I-cell_type
cells	I-cell_type
but	O
is	O
rapidly	O
induced	O
at	O
the	O
transcriptional	O
level	O
following	O
activation	O
through	O
the	O
cell	B-protein
surface	I-protein
T-cell	I-protein
receptor	I-protein
.	O

A	O
highly	O
conserved	O
19-bp	O
element	O
located	O
immediately	O
5	O
'	O
of	O
the	O
human	B-DNA
GM-CSF	I-DNA
TATA	I-DNA
box	I-DNA
(	O
bp	B-DNA
-34	I-DNA
to	I-DNA
-52	I-DNA
)	O
,	O
herein	O
called	O
purine	B-DNA
box	I-DNA
1	I-DNA
(	O
PB1	B-DNA
)	O
,	O
has	O
been	O
shown	O
to	O
bind	O
a	O
T-cell	B-protein
nuclear	I-protein
protein	I-protein
complex	I-protein
and	O
to	O
be	O
required	O
for	O
transcriptional	O
induction	O
of	O
the	O
GM-CSF	B-DNA
gene	I-DNA
following	O
T-cell	O
activation	O
.	O

The	O
PB1	B-DNA
sequence	O
motif	O
is	O
highly	O
conserved	O
in	O
both	O
human	B-DNA
and	I-DNA
murine	I-DNA
GM-CSF	I-DNA
genes	I-DNA
.	O

In	O
this	O
report	O
,	O
we	O
demonstrate	O
that	O
the	O
PB1	B-DNA
element	I-DNA
alone	O
confers	O
inducibility	O
on	O
a	O
heterologous	O
promoter	O
following	O
transfection	O
into	O
human	B-cell_line
Jurkat	I-cell_line
T	I-cell_line
cells	I-cell_line
.	O

In	O
addition	O
,	O
we	O
identify	O
a	O
major	O
PB1	B-protein
nuclear	I-protein
protein-binding	I-protein
complex	I-protein
that	O
is	O
not	O
present	O
in	O
resting	B-cell_type
peripheral	I-cell_type
blood	I-cell_type
T	I-cell_type
cells	I-cell_type
but	O
is	O
rapidly	O
induced	O
following	O
T-cell	O
activation	O
.	O

Sequence	O
analysis	O
revealed	O
that	O
PB1	B-DNA
is	O
composed	O
of	O
adjacent	B-DNA
binding	I-DNA
sites	I-DNA
for	O
Ets	B-protein
and	O
AP-1	B-protein
transcription	B-protein
factors	I-protein
.	O

In	O
vitro	O
mutagenesis	O
experiments	O
demonstrated	O
that	O
both	O
the	O
Ets	B-DNA
and	I-DNA
AP-1	I-DNA
sites	I-DNA
are	O
required	O
for	O
binding	O
of	O
the	O
inducible	O
PB1	B-protein
nuclear	I-protein
protein	I-protein
complex	I-protein
and	O
for	O
the	O
transcriptional	O
activity	O
of	O
this	O
element	O
and	O
the	O
GM-CSF	B-DNA
promoter	I-DNA
in	O
activated	B-cell_type
T	I-cell_type
cells	I-cell_type
.	O

(	O
ABSTRACT	O
TRUNCATED	O
AT	O
250	O
WORDS	O
)	O

MoLECcULAR	NULL
AND	NULL
CELLULAR	NULL
BIOLOGY	NULL
,	NULL
Feb.	NULL
1994	NULL
,	NULL
p.	NULL
1153-1159	NULL
0270-7306/94/	NULL
$	NULL
04.00+0	NULL
Copyright	NULL
©	NULL
1994	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

14	NULL
,	NULL
No	NULL
.	NULL

2	NULL
Activation	NULL
of	NULL
the	NULL
Granulocyte-Macrophage	NULL
Colony-Stimulating	NULL
Factor	NULL
Promoter	NULL
in	NULL
T	NULL
Cells	NULL
Requires	NULL
Cooperative	NULL
Binding	NULL
of	NULL
Elf-1	NULL
and	NULL
AP-1	NULL
Transcription	NULL
Factors	NULL
CHUNG-YIH	NULL
WANG	NULL
,	NULL
ALEXANDER	NULL
G.	NULL
BASSUK	NULL
,	NULL
*	NULL
LAWRENCE	NULL
H.	NULL
BOISE	NULL
,	NULL
``	NULL
>	NULL
*	NULL
CRAIG	NULL
B.	NULL
THOMPSON	NULL
,	NULL
*	NULL
>	NULL
*	NULL
RODRIGO	NULL
BRAVO	NULL
,	NULL
*	NULL
anp	NULL
JEFFREY	NULL
M.	NULL
LEIDEN®'**	NULL
Departments	NULL
of	NULL
Medicine	NULL
,	NULL
``	NULL
Pathology	NULL
,	NULL
``	NULL
and	NULL
Molecular	NULL
Genetics	NULL
and	NULL
Cell	NULL
Biology®	NULL
and	NULL
The	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
,	NULL
``	NULL
University	NULL
of	NULL
Chicago	NULL
,	NULL
Chicago	NULL
,	NULL
Illinois	NULL
60637	NULL
,	NULL
and	NULL
Bristol-Myers	NULL
Squibb	NULL
Pharmaceutical	NULL
Research	NULL
Institute	NULL
,	NULL
Princeton	NULL
,	NULL
New	NULL
Jersey	NULL
08543	NULL
``	NULL
Received	NULL
12	NULL
May	NULL
1993/Returned	NULL
for	NULL
modification	NULL
20	NULL
July	NULL
1993/Accepted	NULL
8	NULL
November	NULL
1993	NULL
The	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
GM-CSF	NULL
)	NULL
gene	NULL
has	NULL
been	NULL
studied	NULL
extensively	NULL
as	NULL
a	NULL
model	NULL
system	NULL
of	NULL
transcriptional	NULL
induction	NULL
during	NULL
T-lymphocyte	NULL
activation	NULL
.	NULL

The	NULL
GM-CSF	NULL
gene	NULL
is	NULL
not	NULL
expressed	NULL
in	NULL
resting	NULL
peripheral	NULL
blood	NULL
T	NULL
cells	NULL
but	NULL
is	NULL
rapidly	NULL
induced	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
following	NULL
activation	NULL
through	NULL
the	NULL
cell	NULL
surface	NULL
T-cell	NULL
receptor	NULL
.	NULL

A	NULL
highly	NULL
conserved	NULL
19-bp	NULL
element	NULL
located	NULL
immediately	NULL
5	NULL
'	NULL
of	NULL
the	NULL
human	NULL
GM-CSF	NULL
TATA	NULL
box	NULL
(	NULL
bp	NULL
-34	NULL
to	NULL
-52	NULL
)	NULL
,	NULL
herein	NULL
called	NULL
purine	NULL
box	NULL
1	NULL
(	NULL
PB1	NULL
)	NULL
,	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
bind	NULL
a	NULL
T-cell	NULL
nuclear	NULL
protein	NULL
complex	NULL
and	NULL
to	NULL
be	NULL
required	NULL
for	NULL
transcriptional	NULL
induction	NULL
of	NULL
the	NULL
GM-CSF	NULL
gene	NULL
following	NULL
T-cell	NULL
activation	NULL
.	NULL

The	NULL
PB1	NULL
sequence	NULL
motif	NULL
is	NULL
highly	NULL
conserved	NULL
in	NULL
both	NULL
human	NULL
and	NULL
murine	NULL
GM-CSF	NULL
genes	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
the	NULL
PB1	NULL
element	NULL
alone	NULL
confers	NULL
inducibility	NULL
on	NULL
a	NULL
heterologous	NULL
promoter	NULL
following	NULL
transfection	NULL
into	NULL
human	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
identify	NULL
a	NULL
major	NULL
PB1	NULL
nuclear	NULL
protein-binding	NULL
complex	NULL
that	NULL
is	NULL
not	NULL
present	NULL
in	NULL
resting	NULL
peripheral	NULL
blood	NULL
T	NULL
cells	NULL
but	NULL
is	NULL
rapidly	NULL
induced	NULL
following	NULL
T-cell	NULL
activation	NULL
.	NULL

Sequence	NULL
analysis	NULL
revealed	NULL
that	NULL
PBI	NULL
is	NULL
composed	NULL
of	NULL
adjacent	NULL
binding	NULL
sites	NULL
for	NULL
Ets	NULL
and	NULL
AP-1	NULL
transcription	NULL
factors	NULL
.	NULL

In	NULL
vitro	NULL
mutagenesis	NULL
experiments	NULL
demonstrated	NULL
that	NULL
both	NULL
the	NULL
Ets	NULL
and	NULL
AP-1	NULL
sites	NULL
are	NULL
required	NULL
for	NULL
binding	NULL
of	NULL
the	NULL
inducible	NULL
PB1	NULL
nuclear	NULL
protein	NULL
complex	NULL
and	NULL
for	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
this	NULL
element	NULL
and	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

Using	NULL
antibodies	NULL
specific	NULL
for	NULL
different	NULL
Ets	NULL
and	NULL
AP-1	NULL
family	NULL
members	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
the	NULL
major	NULL
inducible	NULL
PB1-binding	NULL
activity	NULL
present	NULL
in	NULL
activated	NULL
T-cell	NULL
nuclear	NULL
extracts	NULL
is	NULL
composed	NULL
of	NULL
the	NULL
Elf-1	NULL
,	NULL
c-Fos	NULL
,	NULL
and	NULL
JunB	NULL
transcription	NULL
factors	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
cooperative	NULL
interactions	NULL
between	NULL
specific	NULL
Ets	NULL
and	NULL
AP-1	NULL
family	NULL
members	NULL
are	NULL
important	NULL
in	NULL
regulating	NULL
inducible	NULL
gene	NULL
expression	NULL
following	NULL
T-cell	NULL
activation	NULL
.	NULL

The	NULL
activation	NULL
of	NULL
normal	NULL
peripheral	NULL
blood	NULL
T	NULL
cells	NULL
results	NULL
in	NULL
the	NULL
precisely	NULL
orchestrated	NULL
transcriptional	NULL
induction	NULL
of	NULL
more	NULL
than	NULL
100	NULL
new	NULL
genes	NULL
,	NULL
many	NULL
of	NULL
which	NULL
are	NULL
important	NULL
mediators	NULL
of	NULL
the	NULL
inflammatory	NULL
response	NULL
to	NULL
foreign	NULL
pathogens	NULL
(	NULL
7	NULL
)	NULL
.	NULL

Activation-specific	NULL
T-cell	NULL
genes	NULL
include	NULL
those	NULL
encoding	NULL
cell	NULL
surface	NULL
molecules	NULL
that	NULL
induce	NULL
important	NULL
changes	NULL
in	NULL
T-cell	NULL
adhesion	NULL
as	NULL
well	NULL
as	NULL
a	NULL
number	NULL
of	NULL
lymphokines	NULL
,	NULL
such	NULL
as	NULL
IL-2	NULL
(	NULL
interleukin-2	NULL
)	NULL
,	NULL
IL-3	NULL
,	NULL
gamma	NULL
interferon	NULL
,	NULL
and	NULL
GM-CSF	NULL
(	NULL
gran-ulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
)	NULL
,	NULL
which	NULL
can	NULL
function	NULL
in	NULL
both	NULL
autocrine	NULL
and	NULL
paracrine	NULL
pathways	NULL
to	NULL
control	NULL
the	NULL
proliferation	NULL
and	NULL
function	NULL
of	NULL
multiple	NULL
inflammatory	NULL
cell	NULL
types	NULL
(	NULL
7	NULL
)	NULL
.	NULL

Given	NULL
the	NULL
importance	NULL
of	NULL
inducible	NULL
T-cell	NULL
genes	NULL
in	NULL
modulating	NULL
the	NULL
inflammatory	NULL
response	NULL
,	NULL
the	NULL
elucidation	NULL
of	NULL
the	NULL
molecular	NULL
mechanisms	NULL
underlying	NULL
inducible	NULL
transcription	NULL
in	NULL
T	NULL
cells	NULL
may	NULL
yield	NULL
important	NULL
insights	NULL
into	NULL
both	NULL
normal	NULL
and	NULL
pathophysiological	NULL
T-cell	NULL
function	NULL
.	NULL

Several	NULL
genes	NULL
have	NULL
been	NULL
characterized	NULL
extensively	NULL
as	NULL
model	NULL
systems	NULL
for	NULL
understanding	NULL
inducible	NULL
transcription	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

These	NULL
include	NULL
the	NULL
IL-2	NULL
(	NULL
2	NULL
,	NULL
4	NULL
,	NULL
8	NULL
,	NULL
10	NULL
)	NULL
,	NULL
IL-3	NULL
(	NULL
27	NULL
,	NULL
30	NULL
)	NULL
,	NULL
GM-CSF	NULL
(	NULL
5	NULL
,	NULL
6	NULL
,	NULL
24	NULL
)	NULL
,	NULL
and	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
1	NULL
,	NULL
18	NULL
,	NULL
20	NULL
,	NULL
22	NULL
)	NULL
genes	NULL
.	NULL

The	NULL
GM-CSF	NULL
gene	NULL
is	NULL
among	NULL
the	NULL
best	NULL
characterized	NULL
of	NULL
these	NULL
inducible	NULL
T-cell	NULL
genes	NULL
.	NULL

GM-CSF	NULL
is	NULL
a	NULL
potent	NULL
cytokine	NULL
that	NULL
stimulates	NULL
the	NULL
proliferation	NULL
and	NULL
maturation	NULL
of	NULL
several	NULL
hematopoietic	NULL
lineages	NULL
,	NULL
including	NULL
neutrophils	NULL
,	NULL
macrophages	NULL
,	NULL
and	NULL
eosinophils	NULL
(	NULL
6	NULL
,	NULL
11	NULL
,	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
BRH	NULL
B608	NULL
MC6080	NULL
,	NULL
University	NULL
of	NULL
Chicago	NULL
,	NULL
5841	NULL
S.	NULL
Maryland	NULL
Ave.	NULL
,	NULL
Chicago	NULL
,	NULL
IL	NULL
60637	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
312	NULL
)	NULL
702-1919	NULL
.	NULL

Fax	NULL
:	NULL
(	NULL
312	NULL
)	NULL
702-1385	NULL
.	NULL

1153	NULL
23	NULL
,	NULL
35	NULL
)	NULL
.	NULL

GM-CSF	NULL
is	NULL
not	NULL
expressed	NULL
in	NULL
resting	NULL
T	NULL
cells	NULL
but	NULL
is	NULL
induced	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
during	NULL
the	NULL
first	NULL
20	NULL
h	NULL
following	NULL
T-cell	NULL
activation	NULL
(	NULL
6	NULL
)	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
the	NULL
transcriptional	NULL
induction	NULL
of	NULL
the	NULL
human	NULL
GM-CSF	NULL
gene	NULL
in	NULL
T	NULL
cells	NULL
is	NULL
mediated	NULL
at	NULL
least	NULL
in	NULL
part	NULL
by	NULL
a	NULL
90-bp	NULL
element	NULL
located	NULL
directly	NULL
upstream	NULL
of	NULL
the	NULL
transcriptional	NULL
start	NULL
site	NULL
(	NULL
bp	NULL
-53	NULL
to	NULL
+37	NULL
)	NULL
(	NULL
29	NULL
)	NULL
.	NULL

DNase	NULL
I	NULL
footprint	NULL
analyses	NULL
of	NULL
this	NULL
promoter	NULL
element	NULL
demonstrated	NULL
binding	NULL
of	NULL
a	NULL
T-cell	NULL
nuclear	NULL
protein	NULL
complex	NULL
to	NULL
a	NULL
19-bp	NULL
purine-rich	NULL
region	NULL
(	NULL
herein	NULL
called	NULL
purine	NULL
box	NULL
1	NULL
[	NULL
PB1	NULL
]	NULL
)	NULL
located	NULL
between	NULL
bp	NULL
-34	NULL
and	NULL
-52	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Subsequent	NULL
in	NULL
vitro	NULL
mutagenesis	NULL
experiments	NULL
demonstrated	NULL
that	NULL
this	NULL
region	NULL
is	NULL
required	NULL
for	NULL
the	NULL
inducible	NULL
expression	NULL
of	NULL
the	NULL
intact	NULL
GM-CSF	NULL
promoter	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
PB1	NULL
sequence	NULL
motif	NULL
is	NULL
highly	NULL
conserved	NULL
in	NULL
both	NULL
the	NULL
murine	NULL
and	NULL
human	NULL
GM-CSF	NULL
genes	NULL
(	NULL
24	NULL
)	NULL
and	NULL
is	NULL
also	NULL
present	NULL
in	NULL
the	NULL
5	NULL
flanking	NULL
regions	NULL
of	NULL
the	NULL
human	NULL
and	NULL
murine	NULL
IL-5	NULL
genes	NULL
(	NULL
29	NULL
)	NULL
.	NULL

Although	NULL
these	NULL
previous	NULL
studies	NULL
demonstrated	NULL
that	NULL
the	NULL
PB1	NULL
element	NULL
is	NULL
required	NULL
for	NULL
inducible	NULL
expression	NULL
of	NULL
the	NULL
GM-CSF	NULL
gene	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
it	NULL
remained	NULL
unclear	NULL
whether	NULL
this	NULL
element	NULL
alone	NULL
was	NULL
sufficient	NULL
to	NULL
confer	NULL
inducible	NULL
expression	NULL
on	NULL
a	NULL
minimal	NULL
promoter	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

More	NULL
importantly	NULL
,	NULL
the	NULL
identities	NULL
of	NULL
the	NULL
transcription	NULL
factors	NULL
that	NULL
bind	NULL
to	NULL
PBI	NULL
to	NULL
mediate	NULL
GM-CSF	NULL
transcriptional	NULL
activation	NULL
remained	NULL
unclear	NULL
.	NULL

In	NULL
the	NULL
studies	NULL
described	NULL
in	NULL
this	NULL
report	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
(	NULL
i	NULL
)	NULL
the	NULL
PB1	NULL
element	NULL
alone	NULL
,	NULL
when	NULL
multimerized	NULL
upstream	NULL
of	NULL
a	NULL
minimal	NULL
promoter	NULL
,	NULL
functions	NULL
as	NULL
an	NULL
inducible	NULL
transcriptional	NULL
element	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
(	NULL
ii	NULL
)	NULL
PBI	NULL
is	NULL
composed	NULL
of	NULL
adjacent	NULL
Ets	NULL
and	NULL
AP-1	NULL
binding	NULL
sites	NULL
,	NULL
both	NULL
of	NULL
which	NULL
are	NULL
required	NULL
for	NULL
1154	NULL
WANG	NULL
ET	NULL
AL	NULL
.	NULL

binding	NULL
of	NULL
an	NULL
inducible	NULL
T-cell	NULL
nuclear	NULL
complex	NULL
and	NULL
for	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
PBI	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
,	NULL
(	NULL
iii	NULL
)	NULL
both	NULL
the	NULL
Ets	NULL
and	NULL
AP-1	NULL
binding	NULL
sites	NULL
are	NULL
also	NULL
required	NULL
for	NULL
the	NULL
inducible	NULL
activity	NULL
of	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
(	NULL
iv	NULL
)	NULL
the	NULL
major	NULL
inducible	NULL
PB1-binding	NULL
complex	NULL
in	NULL
activated	NULL
T-cell	NULL
nuclear	NULL
extracts	NULL
contains	NULL
Elf-1	NULL
,	NULL
c-Fos	NULL
,	NULL
and	NULL
JunB	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
cooperative	NULL
binding	NULL
of	NULL
specific	NULL
Ets	NULL
and	NULL
AP-1	NULL
family	NULL
members	NULL
to	NULL
inducible	NULL
promoters	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
regulating	NULL
activation-specific	NULL
gene	NULL
expression	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cells	NULL
and	NULL
cell	NULL
lines	NULL
.	NULL

Human	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
(	NULL
PBL	NULL
)	NULL
were	NULL
isolated	NULL
from	NULL
buffy	NULL
coats	NULL
obtained	NULL
by	NULL
leukapher-esis	NULL
of	NULL
healthy	NULL
21-	NULL
to	NULL
31-year-old	NULL
donors	NULL
by	NULL
density	NULL
gradient	NULL
centrifugation	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Purified	NULL
cells	NULL
were	NULL
>	NULL
99	NULL
%	NULL
lymphocytes	NULL
as	NULL
determined	NULL
by	NULL
Wright	NULL
staining	NULL
.	NULL

Viability	NULL
was	NULL
greater	NULL
than	NULL
99	NULL
%	NULL
as	NULL
measured	NULL
by	NULL
trypan	NULL
blue	NULL
exclusion	NULL
.	NULL

PBL	NULL
were	NULL
cultured	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
2	NULL
x	NULL
10	NULL
%	NULL
/ml	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
(	NULL
GIBCO	NULL
,	NULL
Grand	NULL
Island	NULL
,	NULL
N.Y.	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
heat-inactivated	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
GIBCO	NULL
)	NULL
,	NULL
2	NULL
mM	NULL
L-glutamine	NULL
,	NULL
100	NULL
U	NULL
of	NULL
penicillin	NULL
G	NULL
per	NULL
mil	NULL
,	NULL
100	NULL
ug	NULL
of	NULL
streptomycin	NULL
per	NULL
ml	NULL
,	NULL
and	NULL
15	NULL
mM	NULL
N-2-hydroxyeth-ylipiperazine-N'-2-ethanesulfonic	NULL
acid	NULL
(	NULL
HEPES	NULL
;	NULL
pH	NULL
7.4	NULL
)	NULL
(	NULL
GIBCO	NULL
)	NULL
.	NULL

PBL	NULL
were	NULL
activated	NULL
by	NULL
treatment	NULL
for	NULL
6	NULL
to	NULL
8	NULL
h	NULL
with	NULL
phorbol	NULL
myristate	NULL
acetate	NULL
(	NULL
PMA	NULL
;	NULL
10	NULL
ng/ml	NULL
)	NULL
plus	NULL
ionomycin	NULL
(	NULL
0.4	NULL
pg/ml	NULL
)	NULL
.	NULL

Human	NULL
Jurkat	NULL
and	NULL
murine	NULL
ELA	NULL
T-cell	NULL
tumor	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
and	NULL
penicillin-streptomycin	NULL
(	NULL
GIBCO	NULL
)	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Plasmids	NULL
.	NULL

The	NULL
GM-CSFCAT	NULL
,	NULL
mEIf-1CAT	NULL
,	NULL
and	NULL
mAP-1CAT	NULL
plasmids	NULL
were	NULL
made	NULL
by	NULL
cloning	NULL
three	NULL
copies	NULL
of	NULL
the	NULL
following	NULL
synthetic	NULL
oligonucleotides	NULL
into	NULL
the	NULL
Smal	NULL
site	NULL
of	NULL
pSPCAT	NULL
(	NULL
31	NULL
)	NULL
:	NULL
GM-CSFCAT	NULL
,	NULL
ACAGTTAGAGGAAATGAT	NULL
TAATGGTG	NULL
;	NULL
mEIf-1CAT	NULL
,	NULL
ACAGTTATGCCAAATGATT	NULL
AATGGTG	NULL
;	NULL
and	NULL
mAP-1CAT	NULL
,	NULL
ACAGTTAGAGGAAATAT	NULL
TGGATGGTG	NULL
.	NULL

The	NULL
GM-CSFPrLuc	NULL
plasmid	NULL
was	NULL
made	NULL
by	NULL
cloning	NULL
the	NULL
human	NULL
GM-CSF	NULL
promoter	NULL
(	NULL
bp	NULL
-55	NULL
to	NULL
+39	NULL
)	NULL
into	NULL
the	NULL
HindIII	NULL
sites	NULL
of	NULL
the	NULL
pGL2-Basic	NULL
vector	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
Wis.	NULL
)	NULL
.	NULL

The	NULL
GM-CSFPrmEIf-1Luc	NULL
and	NULL
GM-CSFPrmAP-1	NULL
Lue	NULL
plasmids	NULL
are	NULL
identical	NULL
to	NULL
GM-CSFPrLuc	NULL
except	NULL
that	NULL
they	NULL
contain	NULL
mutations	NULL
in	NULL
the	NULL
Elf-1	NULL
and	NULL
AP-1	NULL
sites	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

The	NULL
pRSVBgal	NULL
reference	NULL
plasmid	NULL
,	NULL
in	NULL
which	NULL
the	NULL
bacterial	NULL
lacZ	NULL
gene	NULL
is	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
Rous	NULL
sarcoma	NULL
virus	NULL
long	NULL
terminal	NULL
repeat	NULL
,	NULL
has	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
9	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
.	NULL

Normal	NULL
human	NULL
PBL	NULL
were	NULL
washed	NULL
with	NULL
phosphate-buffered	NULL
saline	NULL
and	NULL
incubated	NULL
in	NULL
buffer	NULL
A	NULL
(	NULL
10	NULL
mM	NULL
HEPES	NULL
[	NULL
pH	NULL
7.9	NULL
]	NULL
,	NULL
1.5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
10	NULL
mM	NULL
KCI	NULL
,	NULL
0.5	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
0.2	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
)	NULL
for	NULL
10	NULL
min	NULL
at	NULL
4°C	NULL
.	NULL

Cells	NULL
were	NULL
collected	NULL
by	NULL
centrifugation	NULL
at	NULL
1,500	NULL
x	NULL
g	NULL
for	NULL
2	NULL
min	NULL
and	NULL
lysed	NULL
by	NULL
incubation	NULL
in	NULL
buffer	NULL
C	NULL
(	NULL
20	NULL
mM	NULL
HEPES	NULL
[	NULL
pH	NULL
7.9	NULL
}	NULL
,	NULL
25	NULL
%	NULL
glycerol	NULL
,	NULL
420	NULL
mM	NULL
NaCl	NULL
,	NULL
1.5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
0.2	NULL
mM	NULL
EDTA	NULL
,	NULL
0.5	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
0.2	NULL
mM	NULL
phenylmethyisulfonyl	NULL
fluoride	NULL
)	NULL
at	NULL
4°C	NULL
for	NULL
20	NULL
min	NULL
.	NULL

Lysates	NULL
were	NULL
cleared	NULL
by	NULL
centrifugation	NULL
at	NULL
15,000	NULL
x	NULL
g	NULL
for	NULL
2	NULL
min	NULL
at	NULL
4°C	NULL
,	NULL
aliquoted	NULL
,	NULL
and	NULL
frozen	NULL
at	NULL
-70°C	NULL
.	NULL

Protein	NULL
concentrations	NULL
were	NULL
determined	NULL
by	NULL
using	NULL
a	NULL
commercially	NULL
available	NULL
kit	NULL
(	NULL
Bio-Rad	NULL
,	NULL
Richmond	NULL
,	NULL
Calif.	NULL
)	NULL
.	NULL

EMSAs	NULL
.	NULL

The	NULL
following	NULL
double-stranded	NULL
oligonucleotides	NULL
containing	NULL
overhanging	NULL
BamHI-Bgill	NULL
ends	NULL
were	NULL
synthesized	NULL
on	NULL
an	NULL
Applied	NULL
Biosystems	NULL
model	NULL
380B	NULL
DNA	NULL
synthesizer	NULL
and	NULL
labeled	NULL
with	NULL
*°P-nucleotides	NULL
by	NULL
fill-in	NULL
with	NULL
the	NULL
Klenow	NULL
fragment	NULL
of	NULL
DNA	NULL
polymerase	NULL
I	NULL
prior	NULL
to	NULL
use	NULL
in	NULL
electro-	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

phoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSAs	NULL
)	NULL
:	NULL
GM-CSF	NULL
,	NULL
ACAGT	NULL
TAGAGGAAATGATTAATGGTG	NULL
;	NULL
mElf-1	NULL
,	NULL
ACAGTTATG	NULL
CCAAATGATTAATGGTG	NULL
;	NULL
mAP-1	NULL
,	NULL
ACAGTTAGAGGAA	NULL
ATATTGGATGGTG	NULL
;	NULL
Ta3	NULL
,	NULL
GAGATAGCATCGCCCCAG	NULL
GCCACGTGCCGAG	NULL
;	NULL
Tal	NULL
,	NULL
CTCCCATTITTCCATGACGTC	NULL
ATGGTTACCA	NULL
;	NULL
and	NULL
mNIP	NULL
,	NULL
GATCCACCTTCTITTCACT	NULL
TGTTCCCA	NULL
.	NULL

Mixtures	NULL
for	NULL
binding	NULL
reactions	NULL
using	NULL
T-cell	NULL
nuclear	NULL
extracts	NULL
contained	NULL
2.0	NULL
pug	NULL
of	NULL
T-cell	NULL
nuclear	NULL
protein	NULL
,	NULL
30,000	NULL
dpM	NULL
(	NULL
0.1	NULL
to	NULL
0.5	NULL
ng	NULL
)	NULL
of	NULL
radiolabeled	NULL
oligonucleotide	NULL
probe	NULL
,	NULL
250	NULL
ng	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
in	NULL
50	NULL
mM	NULL
KCl	NULL
,	NULL
10	NULL
mM	NULL
Tris	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
,	NULL
10	NULL
mM	NULL
HEPES	NULL
,	NULL
1.25	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
1.1	NULL
mM	NULL
EDTA	NULL
,	NULL
and	NULL
15	NULL
%	NULL
(	NULL
vol/vol	NULL
)	NULL
glycerol	NULL
in	NULL
a	NULL
final	NULL
reaction	NULL
volume	NULL
of	NULL
15	NULL
pul	NULL
.	NULL

Following	NULL
incubation	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
30	NULL
min	NULL
,	NULL
DNA-protein	NULL
complexes	NULL
were	NULL
fractionated	NULL
by	NULL
electrophoresis	NULL
in	NULL
nondena-turing	NULL
5	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
at	NULL
120	NULL
V	NULL
for	NULL
4	NULL
h	NULL
at	NULL
4°C	NULL
in	NULL
TBE	NULL
buffer	NULL
(	NULL
0.089	NULL
M	NULL
Tris-borate	NULL
,	NULL
0.089	NULL
M	NULL
boric	NULL
acid	NULL
,	NULL
0.002	NULL
M	NULL
EDTA	NULL
)	NULL
.	NULL

For	NULL
competition	NULL
experiments	NULL
,	NULL
5	NULL
or	NULL
50	NULL
ng	NULL
of	NULL
unlabeled	NULL
competitor	NULL
oligonucleotide	NULL
was	NULL
added	NULL
to	NULL
the	NULL
binding	NULL
reactions	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
radiolabeled	NULL
oligonucleotide	NULL
probe	NULL
.	NULL

For	NULL
antibody	NULL
supershift	NULL
experiments	NULL
,	NULL
1	NULL
to	NULL
2	NULL
pl	NULL
of	NULL
the	NULL
appropriate	NULL
antibody	NULL
was	NULL
added	NULL
to	NULL
nuclear	NULL
extract	NULL
and	NULL
incubated	NULL
at	NULL
4°C	NULL
for	NULL
15	NULL
min	NULL
prior	NULL
to	NULL
use	NULL
in	NULL
EMSAs	NULL
as	NULL
described	NULL
above	NULL
.	NULL

All	NULL
gels	NULL
were	NULL
dried	NULL
and	NULL
subjected	NULL
to	NULL
autoradiography	NULL
using	NULL
intensifying	NULL
screens	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
31	NULL
)	NULL
.	NULL

Transfections	NULL
and	NULL
CAT	NULL
assays	NULL
.	NULL

Exponentially	NULL
growing	NULL
cultures	NULL
containing	NULL
10°	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
reporter	NULL
plasmid	NULL
and	NULL
1	NULL
ug	NULL
of	NULL
the	NULL
pRSVRBgal	NULL
reference	NULL
plasmid	NULL
,	NULL
using	NULL
DEAE-dextran	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
31	NULL
)	NULL
.	NULL

Transfections	NULL
of	NULL
murine	NULL
ELA	NULL
cells	NULL
were	NULL
identical	NULL
except	NULL
that	NULL
they	NULL
were	NULL
done	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
reporter	NULL
plasmid	NULL
.	NULL

Thirty-six	NULL
hours	NULL
after	NULL
transfection	NULL
,	NULL
cultures	NULL
were	NULL
treated	NULL
with	NULL
medium	NULL
alone	NULL
or	NULL
PMA	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
plus	NULL
ionomycin	NULL
(	NULL
1.5	NULL
pg/ml	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
10	NULL
to	NULL
12	NULL
h	NULL
after	NULL
stimulation	NULL
,	NULL
and	NULL
cell	NULL
extracts	NULL
normalized	NULL
for	NULL
protein	NULL
content	NULL
by	NULL
using	NULL
a	NULL
commercially	NULL
available	NULL
kit	NULL
(	NULL
Bio-Rad	NULL
)	NULL
were	NULL
assayed	NULL
for	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
and	NULL
B-galactosidase	NULL
activities	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
31	NULL
)	NULL
.	NULL

Antibodies	NULL
.	NULL

Preparation	NULL
and	NULL
specificities	NULL
of	NULL
the	NULL
anti-Elf-1	NULL
(	NULL
«	NULL
-Elf-1	NULL
)	NULL
(	NULL
18	NULL
)	NULL
,	NULL
«	NULL
-c-Fos	NULL
(	NULL
17	NULL
)	NULL
,	NULL
«	NULL
-JunB	NULL
(	NULL
17	NULL
)	NULL
,	NULL
«	NULL
-JunD	NULL
(	NULL
17	NULL
)	NULL
,	NULL
a-Fra-1	NULL
(	NULL
17	NULL
)	NULL
,	NULL
and	NULL
a-cyclin	NULL
D1	NULL
(	NULL
21	NULL
)	NULL
rabbit	NULL
antisera	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
.	NULL

The	NULL
«	NULL
-Ets-1	NULL
and	NULL
a-c-Myc	NULL
antibodies	NULL
were	NULL
purchased	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
(	NULL
Santa	NULL
Cruz	NULL
,	NULL
Calif.	NULL
)	NULL
.	NULL

The	NULL
a-Jun	NULL
family	NULL
(	NULL
a	NULL
«	NULL
-Jun	NULL
)	NULL
and	NULL
«	NULL
-fos	NULL
family	NULL
(	NULL
a-Fos	NULL
)	NULL
rabbit	NULL
antisera	NULL
recognize	NULL
all	NULL
known	NULL
members	NULL
of	NULL
the	NULL
Jun	NULL
and	NULL
Fos	NULL
protein	NULL
families	NULL
,	NULL
respectively	NULL
(	NULL
24	NULL
)	NULL
.	NULL

The	NULL
«	NULL
-cyclin	NULL
D1	NULL
rabbit	NULL
antiserum	NULL
was	NULL
the	NULL
generous	NULL
gift	NULL
of	NULL
C.	NULL
Sherr	NULL
(	NULL
21	NULL
)	NULL
.	NULL

RESULTS	NULL
PB1	NULL
contains	NULL
adjacent	NULL
Ets	NULL
and	NULL
AP-1	NULL
binding	NULL
sites	NULL
and	NULL
binds	NULL
an	NULL
inducible	NULL
T-cell	NULL
nuclear	NULL
protein	NULL
complex	NULL
.	NULL

Sequence	NULL
analysis	NULL
of	NULL
the	NULL
PBI	NULL
element	NULL
(	NULL
bp	NULL
-41	NULL
to	NULL
-59	NULL
;	NULL
antisense	NULL
strand	NULL
)	NULL
of	NULL
the	NULL
murine	NULL
GM-CSF	NULL
promoter	NULL
revealed	NULL
the	NULL
presence	NULL
of	NULL
adjacent	NULL
potential	NULL
binding	NULL
sites	NULL
for	NULL
Ets	NULL
(	NULL
A/CGGAA/T	NULL
)	NULL
and	NULL
AP-1	NULL
(	NULL
TGANTCA	NULL
)	NULL
transcription	NULL
factors	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

These	NULL
sites	NULL
have	NULL
been	NULL
highly	NULL
conserved	NULL
in	NULL
the	NULL
human	NULL
GM-CSF	NULL
promoter	NULL
and	NULL
are	NULL
also	NULL
present	NULL
with	NULL
a	NULL
similar	NULL
spacing	NULL
in	NULL
the	NULL
5	NULL
'	NULL
flanking	NULL
regions	NULL
of	NULL
the	NULL
human	NULL
and	NULL
murine	NULL
IL-5	NULL
promoters	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
NFAT	NULL
sites	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
also	NULL
contain	NULL
adjacent	NULL
Ets	NULL
and	NULL
AP-1	NULL
binding	NULL
sites	NULL
,	NULL
both	NULL
of	NULL
which	NULL
have	NULL
been	NULL
shown	NULL
previously	NULL
to	NULL
be	NULL
essential	NULL
for	NULL
binding	NULL
of	NULL
NFAT	NULL
and	NULL
for	NULL
the	NULL
inducible	NULL
function	NULL
of	NULL
this	NULL
element	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
2	NULL
,	NULL
31	NULL
)	NULL
.	NULL

However	NULL
,	NULL
in	NULL
the	NULL
case	NULL
of	NULL
the	NULL
NFAT	NULL
element	NULL
,	NULL
the	NULL
Ets	NULL
and	NULL
AP-1	NULL
binding	NULL
sites	NULL
are	NULL
separated	NULL
by	NULL
3	NULL
Vor	NULL
.	NULL

14	NULL
,	NULL
1994	NULL
A.	NULL
APA	NULL
_	NULL
Ei	NULL
GTGGTCACCATTAATCATTTCCTG	NULL
AACTGTGTeTATAAGA	NULL
N	NULL
mAP-1	NULL
:	NULL
CC	NULL
AT	NULL
``	NULL
5	NULL
_	NULL
-30	NULL
GGCA	NULL
GCTCTTTTGCAGTGAGCCCAGTA	NULL
|	NULL
1	NULL
EH-	NULL
APA	NULL
TeatTe	NULL
Ac	NULL
cGacaaaah	NULL
ac	NULL
ACAGA	NULL
TeacaaaataaaTAAT1G	NULL
GM-CSF	NULL
(	NULL
-39	NULL
to	NULL
-60	NULL
)	NULL
:	NULL
IL-2	NULL
(	NULL
-286	NULL
to	NULL
-262	NULL
)	NULL
:	NULL
IL-5	NULL
(	NULL
-44	NULL
to	NULL
57	NULL
)	NULL
:	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Location	NULL
and	NULL
sequence	NULL
of	NULL
the	NULL
PB1	NULL
element	NULL
from	NULL
the	NULL
murine	NULL
GM-CSF	NULL
promoter	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Nucleotide	NULL
sequence	NULL
of	NULL
the	NULL
proxi-mal	NULL
murine	NULL
GM-CSF	NULL
promoter	NULL
.	NULL

The	NULL
top	NULL
line	NULL
shows	NULL
the	NULL
sequence	NULL
of	NULL
nucleotides	NULL
-63	NULL
to	NULL
+1	NULL
(	NULL
24	NULL
)	NULL
.	NULL

The	NULL
potential	NULL
AP-1	NULL
and	NULL
Elf-1	NULL
binding	NULL
sites	NULL
which	NULL
together	NULL
comprise	NULL
PBI	NULL
are	NULL
boxed	NULL
and	NULL
labeled	NULL
.	NULL

The	NULL
nucleotide	NULL
substitutions	NULL
made	NULL
in	NULL
the	NULL
mutant	NULL
AP-1	NULL
(	NULL
mAP-1	NULL
)	NULL
and	NULL
Elf-1	NULL
(	NULL
mEIf-1	NULL
)	NULL
sequences	NULL
are	NULL
shown	NULL
below	NULL
the	NULL
promoter	NULL
sequence	NULL
.	NULL

The	NULL
nucleotides	NULL
involved	NULL
in	NULL
binding	NULL
the	NULL
inducible	NULL
PBI	NULL
nuclear	NULL
protein	NULL
complex	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
from	NULL
activated	NULL
normal	NULL
human	NULL
T	NULL
cells	NULL
were	NULL
determined	NULL
by	NULL
methylation	NULL
interference	NULL
and	NULL
are	NULL
marked	NULL
(	NULL
@	NULL
)	NULL
in	NULL
panel	NULL
B	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Comparison	NULL
of	NULL
purine-rich	NULL
nuclear	NULL
protein-binding	NULL
sites	NULL
from	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
(	NULL
PB1l	NULL
)	NULL
(	NULL
29	NULL
)	NULL
,	NULL
the	NULL
IL-2	NULL
promoter/enhancer	NULL
(	NULL
NFAT	NULL
)	NULL
(	NULL
31	NULL
)	NULL
,	NULL
and	NULL
the	NULL
IL-5	NULL
promoter	NULL
(	NULL
25	NULL
)	NULL
.	NULL

bp	NULL
,	NULL
whereas	NULL
these	NULL
sites	NULL
are	NULL
directly	NULL
adjacent	NULL
to	NULL
each	NULL
other	NULL
in	NULL
the	NULL
GM-CSF	NULL
and	NULL
IL-5	NULL
promoters	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

The	NULL
significance	NULL
of	NULL
this	NULL
difference	NULL
is	NULL
discussed	NULL
further	NULL
below	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
PB1	NULL
binds	NULL
an	NULL
inducible	NULL
T-cell	NULL
nuclear	NULL
protein	NULL
complex	NULL
and	NULL
,	NULL
if	NULL
so	NULL
,	NULL
whether	NULL
the	NULL
Ets	NULL
and	NULL
AP-1	NULL
sites	NULL
are	NULL
required	NULL
for	NULL
binding	NULL
,	NULL
we	NULL
performed	NULL
a	NULL
series	NULL
of	NULL
EMSAs	NULL
using	NULL
a	NULL
radiolabeled	NULL
PBI	NULL
probe	NULL
and	NULL
nuclear	NULL
extracts	NULL
from	NULL
resting	NULL
or	NULL
activated	NULL
normal	NULL
human	NULL
peripheral	NULL
blood	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
PBI	NULL
binds	NULL
two	NULL
major	NULL
nuclear	NULL
protein	NULL
complexes	NULL
.	NULL

The	NULL
complex	NULL
displaying	NULL
slower	NULL
electrophoretic	NULL
mobility	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
arrow	NULL
)	NULL
was	NULL
barely	NULL
detectable	NULL
in	NULL
resting	NULL
peripheral	NULL
blood	NULL
T-cell	NULL
nuclear	NULL
extracts	NULL
but	NULL
was	NULL
significantly	NULL
induced	NULL
following	NULL
8	NULL
h	NULL
of	NULL
activation	NULL
with	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
.	NULL

This	NULL
inducible	NULL
PB1l-binding	NULL
complex	NULL
represented	NULL
a	NULL
sequence-specific	NULL
DNA-binding	NULL
activity	NULL
because	NULL
it	NULL
was	NULL
efficiently	NULL
competed	NULL
for	NULL
by	NULL
excess	NULL
unlabeled	NULL
PBI	NULL
competitor	NULL
oligonucleotide	NULL
but	NULL
not	NULL
by	NULL
two	NULL
unrelated	NULL
control	NULL
oligonucleotide	NULL
competitors	NULL
,	NULL
Ta3	NULL
and	NULL
mNIP	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Binding	NULL
of	NULL
this	NULL
inducible	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
arrow	NULL
)	NULL
required	NULL
both	NULL
the	NULL
Ets	NULL
and	NULL
AP-1	NULL
sites	NULL
,	NULL
since	NULL
mutations	NULL
in	NULL
either	NULL
site	NULL
abolished	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
resulting	NULL
oligonucleotide	NULL
to	NULL
compete	NULL
for	NULL
binding	NULL
of	NULL
this	NULL
complex	NULL
to	NULL
the	NULL
wild-type	NULL
labeled	NULL
PBI	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
;	NULL
compare	NULL
the	NULL
GM-CSF	NULL
competitor	NULL
with	NULL
the	NULL
mAP-1	NULL
and	NULL
mEIf-1	NULL
competitors	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
methylation	NULL
interference	NULL
experiments	NULL
demonstrated	NULL
that	NULL
G	NULL
residues	NULL
in	NULL
both	NULL
the	NULL
Ets	NULL
and	NULL
AP-1	NULL
sites	NULL
were	NULL
required	NULL
for	NULL
binding	NULL
of	NULL
the	NULL
inducible	NULL
PB1	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
these	NULL
experiments	NULL
demonstrated	NULL
that	NULL
PBIl	NULL
binds	NULL
an	NULL
inducible	NULL
T-cell	NULL
nuclear	NULL
protein	NULL
complex	NULL
and	NULL
that	NULL
this	NULL
binding	NULL
activity	NULL
requires	NULL
both	NULL
the	NULL
Ets	NULL
and	NULL
AP-1	NULL
motifs	NULL
of	NULL
PB1	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
finding	NULL
that	NULL
oligonucleotides	NULL
containing	NULL
mutations	NULL
in	NULL
either	NULL
the	NULL
Ets	NULL
or	NULL
AP-1	NULL
site	NULL
were	NULL
unable	NULL
to	NULL
efficiently	NULL
compete	NULL
for	NULL
binding	NULL
of	NULL
the	NULL
PB1	NULL
complex	NULL
suggests	NULL
that	NULL
PB1	NULL
complex	NULL
formation	NULL
requires	NULL
cooperative	NULL
binding	NULL
of	NULL
proteins	NULL
to	NULL
the	NULL
Ets	NULL
and	NULL
AP-1	NULL
sites	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
the	NULL
inducible	NULL
binding	NULL
complex	NULL
described	NULL
above	NULL
,	NULL
PBI	NULL
bound	NULL
a	NULL
nuclear	NULL
protein	NULL
complex	NULL
that	NULL
displayed	NULL
TRANSCRIPTIONAL	NULL
ACTIVATION	NULL
OF	NULL
THE	NULL
GM-CSF	NULL
PROMOTER	NULL
IN	NULL
T	NULL
CELLS	NULL
1155	NULL
ke	NULL
]	NULL
0	NULL
a=	NULL
P	NULL
+1	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Binding	NULL
of	NULL
an	NULL
inducible	NULL
T-cell	NULL
nuclear	NULL
protein	NULL
complex	NULL
to	NULL
the	NULL
PB1	NULL
motif	NULL
from	NULL
the	NULL
murine	NULL
GM-CSF	NULL
promoter	NULL
.	NULL

A	NULL
radiolabeled	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
PB1	NULL
element	NULL
of	NULL
the	NULL
murine	NULL
GM-CSF	NULL
promoter	NULL
(	NULL
bp	NULL
-33	NULL
to	NULL
-58	NULL
;	NULL
see	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
was	NULL
used	NULL
in	NULL
EMSAs	NULL
with	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
resting	NULL
normal	NULL
human	NULL
peripheral	NULL
blood	NULL
T	NULL
cells	NULL
(	NULL
Med	NULL
)	NULL
or	NULL
duplicate	NULL
cultures	NULL
of	NULL
T	NULL
cells	NULL
activated	NULL
for	NULL
8	NULL
h	NULL
with	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
(	NULL
P	NULL
+	NULL
I	NULL
)	NULL
.	NULL

The	NULL
inducible	NULL
PBl-binding	NULL
activity	NULL
is	NULL
indicated	NULL
by	NULL
an	NULL
arrow	NULL
.	NULL

more	NULL
rapid	NULL
mobility	NULL
by	NULL
EMSAs	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

The	NULL
significance	NULL
of	NULL
this	NULL
complex	NULL
remains	NULL
unclear	NULL
.	NULL

It	NULL
is	NULL
present	NULL
in	NULL
equal	NULL
concentrations	NULL
in	NULL
both	NULL
resting	NULL
and	NULL
activated	NULL
T-cell	NULL
nuclear	NULL
extracts	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
it	NULL
was	NULL
efficiently	NULL
competed	NULL
for	NULL
by	NULL
both	NULL
the	NULL
wild-type	NULL
unlabeled	NULL
PB1	NULL
oligonucleotide	NULL
and	NULL
the	NULL
unlabeled	NULL
PBI	NULL
oligonucleotide	NULL
containing	NULL
mutations	NULL
in	NULL
the	NULL
Ets	NULL
site	NULL
(	NULL
mEIf-1	NULL
)	NULL
but	NULL
was	NULL
not	NULL
competed	NULL
for	NULL
by	NULL
the	NULL
PBI	NULL
oligonucleotide	NULL
containing	NULL
mutations	NULL
in	NULL
the	NULL
AP-1	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
mAP-1	NULL
)	NULL
or	NULL
by	NULL
the	NULL
unrelated	NULL
Ta3	NULL
or	NULL
mNIP	NULL
oligonucleotide	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
appears	NULL
to	NULL
represent	NULL
a	NULL
constitutive	NULL
activity	NULL
which	NULL
binds	NULL
to	NULL
the	NULL
AP-1	NULL
site	NULL
of	NULL
PB1	NULL
.	NULL

Of	NULL
note	NULL
,	NULL
none	NULL
of	NULL
the	NULL
bands	NULL
in	NULL
these	NULL
EMSAs	NULL
are	NULL
competed	NULL
for	NULL
by	NULL
oligonucleotides	NULL
containing	NULL
mutations	NULL
in	NULL
the	NULL
AP-1	NULL
site	NULL
,	NULL
suggesting	NULL
that	NULL
binding	NULL
of	NULL
proteins	NULL
to	NULL
the	NULL
Ets	NULL
site	NULL
of	NULL
the	NULL
PBI	NULL
oligonucleotide	NULL
requires	NULL
simultaneous	NULL
binding	NULL
of	NULL
proteins	NULL
to	NULL
the	NULL
AP-1	NULL
site	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
these	NULL
two	NULL
major	NULL
PB1l-binding	NULL
activities	NULL
,	NULL
a	NULL
third	NULL
minor	NULL
complex	NULL
of	NULL
slower	NULL
electrophoretic	NULL
mobility	NULL
was	NULL
detected	NULL
in	NULL
some	NULL
EMSAs	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

The	NULL
identity	NULL
and	NULL
sequence	NULL
specificity	NULL
of	NULL
this	NULL
binding	NULL
activity	NULL
remains	NULL
unclear	NULL
,	NULL
as	NULL
it	NULL
was	NULL
not	NULL
consistently	NULL
demonstrated	NULL
in	NULL
T-cell	NULL
nuclear	NULL
extracts	NULL
.	NULL

PB1	NULL
confers	NULL
inducible	NULL
expression	NULL
on	NULL
a	NULL
heterologous	NULL
promoter	NULL
following	NULL
T-cell	NULL
activation	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
PBI	NULL
alone	NULL
is	NULL
able	NULL
to	NULL
function	NULL
as	NULL
an	NULL
inducible	NULL
element	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
we	NULL
cloned	NULL
three	NULL
copies	NULL
of	NULL
the	NULL
PBI	NULL
oligonucleotide	NULL
5	NULL
'	NULL
of	NULL
a	NULL
minimal	NULL
simian	NULL
virus	NULL
40	NULL
(	NULL
SV40	NULL
)	NULL
promoter	NULL
and	NULL
bacterial	NULL
CAT	NULL
reporter	NULL
gene	NULL
and	NULL
transfected	NULL
the	NULL
resulting	NULL
plasmid	NULL
into	NULL
human	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

Thirty-six	NULL
hours	NULL
after	NULL
transfection	NULL
,	NULL
the	NULL
cultures	NULL
were	NULL
divided	NULL
in	NULL
half	NULL
;	NULL
one	NULL
half	NULL
was	NULL
treated	NULL
with	NULL
medium	NULL
alone	NULL
for	NULL
10	NULL
h	NULL
,	NULL
while	NULL
the	NULL
other	NULL
half	NULL
was	NULL
activated	NULL
by	NULL
treatment	NULL
with	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
for	NULL
10	NULL
h.	NULL
As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
the	NULL
SV40	NULL
promoter	NULL
alone	NULL
was	NULL
inactive	NULL
in	NULL
both	NULL
resting	NULL
and	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
reporter	NULL
plasmid	NULL
containing	NULL
three	NULL
copies	NULL
of	NULL
the	NULL
wild-type	NULL
PB1	NULL
element	NULL
5	NULL
'	NULL
of	NULL
1156	NULL
WANG	NULL
ET	NULL
AL	NULL
.	NULL

Competitor	NULL
(	NULL
ng	NULL
)	NULL
am-csr	NULL
__|	NULL
__|	NULL
5	NULL
]	NULL
50	NULL
_|	NULL
|	NULL
]	NULL
yaa	NULL
|_	NULL
{	NULL
|	NULL
Flisted	NULL
mNIP	NULL
_|	NULL
|	NULL
|	NULL
1s	NULL
Po	NULL
p	NULL
-LX	NULL
RCL	NULL
.	NULL

mAP-1	NULL
|	NULL
|	NULL
|	NULL
5	NULL
|50	NULL
mElf-1	NULL
7	NULL
|	NULL
|	NULL
|	NULL
1550	NULL
--	NULL
Bs	NULL
Clk	NULL
is	NULL
_.	NULL
Cl	NULL
th	NULL
ace	NULL
pup	NULL
wa	NULL
das	NULL
Oh	NULL
..	NULL
&	NULL
&	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

PBI	NULL
binding	NULL
requires	NULL
both	NULL
AP-1	NULL
and	NULL
Elf-1	NULL
motifs	NULL
.	NULL

A	NULL
radiolabeled	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
PBI	NULL
element	NULL
from	NULL
the	NULL
murine	NULL
GM-CSF	NULL
promoter	NULL
(	NULL
bp	NULL
-33	NULL
to	NULL
-58	NULL
;	NULL
see	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
was	NULL
used	NULL
in	NULL
EMSAs	NULL
with	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
normal	NULL
human	NULL
T	NULL
cells	NULL
activated	NULL
for	NULL
8	NULL
h	NULL
with	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
.	NULL

Unlabeled	NULL
competitor	NULL
oligonucleotides	NULL
(	NULL
5	NULL
or	NULL
50	NULL
ng	NULL
)	NULL
corresponding	NULL
to	NULL
the	NULL
wild-type	NULL
GM-CSF	NULL
probe	NULL
(	NULL
GM-CSF	NULL
)	NULL
or	NULL
mutants	NULL
containing	NULL
nucleotide	NULL
substitutions	NULL
in	NULL
the	NULL
AP-1	NULL
(	NULL
mAP-1	NULL
)	NULL
or	NULL
Elf-1	NULL
(	NULL
mEIf-1	NULL
)	NULL
motif	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
were	NULL
added	NULL
to	NULL
the	NULL
binding	NULL
reaction	NULL
mixtures	NULL
as	NULL
shown	NULL
.	NULL

Ta3	NULL
and	NULL
mNIP	NULL
are	NULL
unrelated	NULL
control	NULL
competitor	NULL
oligonucleotides	NULL
.	NULL

The	NULL
inducible	NULL
PB1-binding	NULL
activity	NULL
corresponding	NULL
to	NULL
that	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
is	NULL
denoted	NULL
with	NULL
an	NULL
arrow	NULL
.	NULL

Note	NULL
that	NULL
this	NULL
binding	NULL
activity	NULL
was	NULL
competed	NULL
for	NULL
only	NULL
by	NULL
the	NULL
wild-type	NULL
unlabeled	NULL
GM-CSF	NULL
oligonucleotide	NULL
,	NULL
not	NULL
by	NULL
mutant	NULL
oligonucleotide	NULL
competitors	NULL
containing	NULL
nucleotide	NULL
substitutions	NULL
in	NULL
either	NULL
the	NULL
AP-1	NULL
or	NULL
Elf-1	NULL
motif	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
noninducible	NULL
PB1-binding	NULL
activity	NULL
that	NULL
displays	NULL
more	NULL
rapid	NULL
electrophoretic	NULL
mobility	NULL
was	NULL
competed	NULL
for	NULL
by	NULL
both	NULL
wild-type	NULL
and	NULL
mElf-1	NULL
oligonucleotides	NULL
but	NULL
not	NULL
by	NULL
the	NULL
mAP-1	NULL
competitor	NULL
.	NULL

the	NULL
SV40	NULL
promoter	NULL
was	NULL
inactive	NULL
in	NULL
resting	NULL
T	NULL
cells	NULL
but	NULL
was	NULL
induced	NULL
36-fold	NULL
following	NULL
T-cell	NULL
activation	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
Ets	NULL
and	NULL
AP-1	NULL
sites	NULL
were	NULL
important	NULL
for	NULL
the	NULL
inducible	NULL
activity	NULL
of	NULL
PB1	NULL
,	NULL
we	NULL
cloned	NULL
three	NULL
copies	NULL
of	NULL
PBI	NULL
oligonucleotides	NULL
containing	NULL
mutations	NULL
in	NULL
either	NULL
the	NULL
Ets	NULL
(	NULL
mEIf-1	NULL
)	NULL
or	NULL
AP-1	NULL
(	NULL
mAP-1	NULL
)	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
upstream	NULL
of	NULL
the	NULL
minimal	NULL
SV40	NULL
promoter	NULL
and	NULL
repeated	NULL
the	NULL
transfections	NULL
into	NULL
Jurkat	NULL
cells	NULL
.	NULL

Mutations	NULL
of	NULL
either	NULL
the	NULL
AP-1	NULL
or	NULL
Ets	NULL
site	NULL
that	NULL
abolished	NULL
binding	NULL
of	NULL
the	NULL
inducible	NULL
PBl-binding	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
also	NULL
abolished	NULL
the	NULL
ability	NULL
of	NULL
PBI	NULL
to	NULL
function	NULL
as	NULL
an	NULL
inducible	NULL
transcriptional	NULL
element	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
both	NULL
the	NULL
Ets	NULL
and	NULL
AP-1	NULL
sites	NULL
in	NULL
PB1	NULL
are	NULL
required	NULL
for	NULL
binding	NULL
of	NULL
an	NULL
activation-specific	NULL
T-cell	NULL
nuclear	NULL
protein	NULL
complex	NULL
and	NULL
for	NULL
the	NULL
inducible	NULL
transcriptional	NULL
activity	NULL
of	NULL
this	NULL
element	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
Ets	NULL
and	NULL
AP-1	NULL
sites	NULL
of	NULL
PB1	NULL
are	NULL
both	NULL
required	NULL
for	NULL
transcriptional	NULL
induction	NULL
of	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
the	NULL
sequences	NULL
located	NULL
between	NULL
bp	NULL
-53	NULL
and	NULL
+37	NULL
of	NULL
the	NULL
human	NULL
GM-CSF	NULL
promoter	NULL
confer	NULL
inducible	NULL
transcriptional	NULL
activity	NULL
on	NULL
a	NULL
reporter	NULL
plasmid	NULL
following	NULL
T-cell	NULL
activation	NULL
(	NULL
28	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
both	NULL
the	NULL
Ets	NULL
and	NULL
AP-1	NULL
sites	NULL
of	NULL
PB1	NULL
are	NULL
required	NULL
for	NULL
transcriptional	NULL
induction	NULL
of	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
we	NULL
constructed	NULL
a	NULL
series	NULL
of	NULL
reporter	NULL
plasmids	NULL
in	NULL
which	NULL
the	NULL
firefly	NULL
luciferase	NULL
gene	NULL
is	NULL
under	NULL
the	NULL
transcriptional	NULL
control	NULL
of	NULL
the	NULL
wild-type	NULL
human	NULL
GM-CSF	NULL
promoter	NULL
(	NULL
bp	NULL
-55	NULL
to	NULL
+39	NULL
)	NULL
(	NULL
GM-CSFPrLuc	NULL
)	NULL
or	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
containing	NULL
mu	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BroL	NULL
.	NULL

A.	NULL
EM1	NULL
__	NULL
APA	NULL
GM-CSF	NULL
:	NULL
-	NULL
ACAGTTAGAGGAAATGATiAAracta	NULL
mElf-1	NULL
:	NULL
Tace	NULL
maAP-1	NULL
:	NULL
AT	NULL
GG	NULL
Fold	NULL
Induction	NULL
g	NULL
8	NULL
8	NULL
8	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Inducible	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
PB1	NULL
element	NULL
requires	NULL
both	NULL
Elf-1	NULL
and	NULL
AP-1	NULL
motifs	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Nucleotide	NULL
sequences	NULL
of	NULL
the	NULL
wild-type	NULL
(	NULL
GM-CSF	NULL
)	NULL
and	NULL
mutant	NULL
AP-1	NULL
(	NULL
mAP-1	NULL
)	NULL
and	NULL
Elf-1	NULL
(	NULL
mEIf-1	NULL
)	NULL
oligonucleotides	NULL
.	NULL

The	NULL
Elf-1	NULL
and	NULL
AP-1	NULL
motifs	NULL
are	NULL
boxed	NULL
and	NULL
labeled	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Transient	NULL
transfections	NULL
using	NULL
PBI	NULL
reporter	NULL
constructs	NULL
.	NULL

Jurkat	NULL
human	NULL
T	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
CAT	NULL
reporter	NULL
constructs	NULL
containing	NULL
three	NULL
copies	NULL
of	NULL
the	NULL
wild-type	NULL
or	NULL
mutant	NULL
PB1	NULL
oligonucleotides	NULL
cloned	NULL
5°	NULL
of	NULL
the	NULL
minimal	NULL
SV40	NULL
promoter	NULL
(	NULL
SV40pr	NULL
)	NULL
(	NULL
left	NULL
)	NULL
.	NULL

As	NULL
a	NULL
negative	NULL
control	NULL
,	NULL
the	NULL
pSPCAT	NULL
reporter	NULL
containing	NULL
the	NULL
minimal	NULL
SV40	NULL
promoter	NULL
but	NULL
lacking	NULL
all	NULL
GM-CSF	NULL
sequences	NULL
was	NULL
used	NULL
in	NULL
a	NULL
parallel	NULL
transfection	NULL
.	NULL

All	NULL
transfection	NULL
mixtures	NULL
also	NULL
contained	NULL
the	NULL
pRSV	NULL
Bgal	NULL
reference	NULL
plasmid	NULL
to	NULL
correct	NULL
for	NULL
differences	NULL
in	NULL
transfection	NULL
efficiencies	NULL
.	NULL

Thirty-six	NULL
hours	NULL
after	NULL
transfection	NULL
,	NULL
the	NULL
cultures	NULL
were	NULL
divided	NULL
in	NULL
half	NULL
.	NULL

Half	NULL
of	NULL
each	NULL
culture	NULL
was	NULL
left	NULL
unstimulated	NULL
,	NULL
while	NULL
the	NULL
other	NULL
half	NULL
was	NULL
activated	NULL
by	NULL
treatment	NULL
with	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
for	NULL
10	NULL
h.	NULL
Cells	NULL
were	NULL
harvested	NULL
,	NULL
and	NULL
CAT	NULL
and	NULL
B-galactosidase	NULL
activities	NULL
were	NULL
determined	NULL
from	NULL
extracts	NULL
normalized	NULL
for	NULL
protein	NULL
content	NULL
.	NULL

Fold	NULL
induction	NULL
=	NULL
CAT	NULL
activity	NULL
in	NULL
activated	NULL
cultures/CAT	NULL
activity	NULL
in	NULL
unstimulated	NULL
cultures	NULL
after	NULL
normalization	NULL
for	NULL
differences	NULL
in	NULL
transfection	NULL
efficiencies	NULL
.	NULL

All	NULL
transfections	NULL
were	NULL
repeated	NULL
three	NULL
to	NULL
five	NULL
times	NULL
.	NULL

The	NULL
standard	NULL
error	NULL
bars	NULL
for	NULL
the	NULL
pSPCAT	NULL
,	NULL
mEIf-1CAT	NULL
,	NULL
and	NULL
mAP-1CAT	NULL
transfections	NULL
are	NULL
too	NULL
small	NULL
to	NULL
be	NULL
shown	NULL
on	NULL
this	NULL
scale	NULL
.	NULL

tations	NULL
in	NULL
the	NULL
Elf-1	NULL
(	NULL
GM-CSFPrmElf-1Luc	NULL
)	NULL
or	NULL
AP-1	NULL
(	NULL
GM-CSFPrmAP-1Luc	NULL
)	NULL
site	NULL
of	NULL
PBI	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

These	NULL
reporter	NULL
constructs	NULL
were	NULL
transfected	NULL
into	NULL
EL4	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
cultures	NULL
were	NULL
divided	NULL
in	NULL
half	NULL
.	NULL

One	NULL
half	NULL
was	NULL
treated	NULL
with	NULL
medium	NULL
alone	NULL
,	NULL
while	NULL
the	NULL
other	NULL
half	NULL
was	NULL
activated	NULL
for	NULL
12	NULL
h	NULL
by	NULL
treatment	NULL
with	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
previous	NULL
results	NULL
(	NULL
28	NULL
)	NULL
,	NULL
the	NULL
wild-type	NULL
GM-CSF	NULL
promoter	NULL
was	NULL
induced	NULL
approximately	NULL
sixfold	NULL
following	NULL
T-cell	NULL
activation	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Mutation	NULL
of	NULL
either	NULL
the	NULL
Elf-1	NULL
or	NULL
AP-1	NULL
site	NULL
decreased	NULL
inducibility	NULL
to	NULL
1.2-	NULL
or	NULL
1.4-fold	NULL
,	NULL
respectively	NULL
.	NULL

Thus	NULL
,	NULL
both	NULL
the	NULL
EIlf-1	NULL
and	NULL
AP-1	NULL
sites	NULL
are	NULL
required	NULL
for	NULL
the	NULL
inducible	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
inducible	NULL
PB1-binding	NULL
complex	NULL
contains	NULL
specific	NULL
AP-1	NULL
and	NULL
Ets	NULL
family	NULL
members	NULL
.	NULL

The	NULL
results	NULL
of	NULL
experiments	NULL
described	NULL
above	NULL
are	NULL
consistent	NULL
with	NULL
a	NULL
model	NULL
in	NULL
which	NULL
the	NULL
cooperative	NULL
binding	NULL
of	NULL
Ets	NULL
and	NULL
AP-1	NULL
transcription	NULL
factors	NULL
to	NULL
PBI1	NULL
is	NULL
required	NULL
for	NULL
the	NULL
inducible	NULL
expression	NULL
of	NULL
the	NULL
GM-CSF	NULL
gene	NULL
following	NULL
T-cell	NULL
activation	NULL
.	NULL

However	NULL
,	NULL
binding-site	NULL
sequence	NULL
analysis	NULL
alone	NULL
is	NULL
insufficient	NULL
to	NULL
determine	NULL
the	NULL
identities	NULL
of	NULL
the	NULL
cognate	NULL
transcription	NULL
factors	NULL
that	NULL
bind	NULL
to	NULL
a	NULL
given	NULL
sequence	NULL
motif	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
remained	NULL
formally	NULL
possible	NULL
that	NULL
one	NULL
or	NULL
more	NULL
non-Ets	NULL
and/or	NULL
non-AP-1	NULL
family	NULL
members	NULL
were	NULL
binding	NULL
to	NULL
PBI	NULL
to	NULL
mediate	NULL
its	NULL
inducible	NULL
transcriptional	NULL
activity	NULL
.	NULL

Moreover	NULL
,	NULL
both	NULL
the	NULL
Ets	NULL
and	NULL
AP-1	NULL
transcription	NULL
factor	NULL
families	NULL
contain	NULL
multiple	NULL
members	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
identities	NULL
of	NULL
the	NULL
putative	NULL
Ets	NULL
and	NULL
AP-1	NULL
PB1-binding	NULL
factors	NULL
remained	NULL
unclear	NULL
.	NULL

Vor	NULL
.	NULL

14	NULL
,	NULL
1994	NULL
Fold	NULL
Induction	NULL
24	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Both	NULL
AP-1	NULL
and	NULL
Ets	NULL
binding	NULL
sites	NULL
are	NULL
required	NULL
for	NULL
inducible	NULL
expression	NULL
of	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

EL4	NULL
T	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
luciferase	NULL
reporter	NULL
constructs	NULL
containing	NULL
the	NULL
wild-type	NULL
GM-CSF	NULL
promoter	NULL
(	NULL
bp	NULL
~55	NULL
to	NULL
+39	NULL
)	NULL
(	NULL
GM-CSFPrLuc	NULL
)	NULL
or	NULL
the	NULL
identical	NULL
promoter	NULL
with	NULL
mutations	NULL
in	NULL
the	NULL
Elf-1	NULL
(	NULL
GM-CSFPrmElf-1Luc	NULL
)	NULL
or	NULL
AP-1	NULL
(	NULL
GM-CSFPrmAP-1Luc	NULL
)	NULL
site	NULL
of	NULL
PBI	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

All	NULL
transfections	NULL
also	NULL
contained	NULL
the	NULL
pRSVBgal	NULL
reference	NULL
plasmid	NULL
.	NULL

Thirty-six	NULL
hours	NULL
after	NULL
transfection	NULL
,	NULL
the	NULL
cultures	NULL
were	NULL
divided	NULL
in	NULL
half	NULL
.	NULL

One	NULL
half	NULL
was	NULL
treated	NULL
with	NULL
medium	NULL
alone	NULL
,	NULL
while	NULL
the	NULL
other	NULL
half	NULL
was	NULL
activated	NULL
with	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
.	NULL

Twelve	NULL
hours	NULL
after	NULL
stimulation	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
cell	NULL
extracts	NULL
equalized	NULL
for	NULL
protein	NULL
content	NULL
were	NULL
assayed	NULL
for	NULL
luciferase	NULL
and	NULL
B-galactosidase	NULL
activities	NULL
.	NULL

The	NULL
results	NULL
are	NULL
expressed	NULL
as	NULL
fold	NULL
induction	NULL
(	NULL
=	NULL
luciferase	NULL
activity	NULL
in	NULL
the	NULL
stimulated	NULL
culture/luciferase	NULL
activity	NULL
in	NULL
the	NULL
unstimulated	NULL
culture	NULL
)	NULL
following	NULL
correction	NULL
for	NULL
differences	NULL
in	NULL
transfection	NULL
efficiencies	NULL
.	NULL

All	NULL
transfections	NULL
were	NULL
repeated	NULL
at	NULL
least	NULL
three	NULL
times	NULL
,	NULL
and	NULL
results	NULL
are	NULL
shown	NULL
as	NULL
mean	NULL
+	NULL
standard	NULL
error	NULL
.	NULL

To	NULL
further	NULL
address	NULL
these	NULL
issues	NULL
,	NULL
we	NULL
examined	NULL
whether	NULL
antibodies	NULL
specific	NULL
for	NULL
individual	NULL
Ets	NULL
and	NULL
AP-1	NULL
family	NULL
members	NULL
would	NULL
bind	NULL
to	NULL
the	NULL
major	NULL
inducible	NULL
PB1-binding	NULL
complex	NULL
present	NULL
in	NULL
activated	NULL
T-cell	NULL
nuclear	NULL
extracts	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
the	NULL
binding	NULL
of	NULL
this	NULL
complex	NULL
was	NULL
completely	NULL
abolished	NULL
by	NULL
«	NULL
-Elf-1	NULL
antibodies	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
and	NULL
C	NULL
,	NULL
«	NULL
-Elf-1	NULL
)	NULL
as	NULL
well	NULL
as	NULL
by	NULL
antisera	NULL
that	NULL
recognize	NULL
all	NULL
Jun	NULL
or	NULL
all	NULL
Fos	NULL
family	NULL
members	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
,	NULL
a-jun	NULL
Family	NULL
and	NULL
«	NULL
-fos	NULL
Family	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggested	NULL
that	NULL
all	NULL
of	NULL
the	NULL
complexes	NULL
contain	NULL
Elf-1	NULL
and	NULL
one	NULL
or	NULL
more	NULL
AP-1	NULL
family	NULL
members	NULL
.	NULL

A	NULL
number	NULL
of	NULL
control	NULL
experiments	NULL
were	NULL
performed	NULL
to	NULL
confirm	NULL
that	NULL
these	NULL
results	NULL
represented	NULL
specific	NULL
inhibition	NULL
of	NULL
binding	NULL
activity	NULL
.	NULL

First	NULL
,	NULL
it	NULL
has	NULL
previously	NULL
been	NULL
shown	NULL
that	NULL
the	NULL
«	NULL
-Elf-1	NULL
antiserum	NULL
used	NULL
in	NULL
these	NULL
studies	NULL
does	NULL
not	NULL
cross-react	NULL
with	NULL
Ets-1	NULL
,	NULL
Ets-2	NULL
,	NULL
or	NULL
GABPa	NULL
(	NULL
18	NULL
,	NULL
32	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
«	NULL
-Elf-1	NULL
antiserum	NULL
does	NULL
not	NULL
affect	NULL
the	NULL
binding	NULL
or	NULL
mobility	NULL
of	NULL
AP-1	NULL
nuclear	NULL
complexes	NULL
to	NULL
consensus	NULL
AP-1	NULL
sites	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
neither	NULL
the	NULL
«	NULL
-Elf-1	NULL
,	NULL
«	NULL
-Jun	NULL
family	NULL
,	NULL
nor	NULL
«	NULL
-fos	NULL
family	NULL
antiserum	NULL
inhibited	NULL
the	NULL
binding	NULL
of	NULL
CREB/ATF	NULL
proteins	NULL
to	NULL
the	NULL
previously	NULL
described	NULL
(	NULL
14	NULL
)	NULL
Tal	NULL
site	NULL
of	NULL
the	NULL
human	NULL
T-cell	NULL
receptor	NULL
a	NULL
enhancer	NULL
.	NULL

Finally	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
incubation	NULL
of	NULL
these	NULL
antisera	NULL
with	NULL
in	NULL
vitro-translated	NULL
Elf-1	NULL
,	NULL
c-Fos	NULL
,	NULL
and	NULL
JunB	NULL
proteins	NULL
under	NULL
conditions	NULL
identical	NULL
to	NULL
those	NULL
used	NULL
in	NULL
the	NULL
EMSAs	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
does	NULL
not	NULL
result	NULL
in	NULL
significant	NULL
proteolytic	NULL
cleavage	NULL
of	NULL
any	NULL
of	NULL
these	NULL
proteins	NULL
(	NULL
data	NULL
not	NULL
TRANSCRIPTIONAL	NULL
ACTIVATION	NULL
OF	NULL
THE	NULL
GM-CSF	NULL
PROMOTER	NULL
IN	NULL
T	NULL
CELLS	NULL
1157	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
finding	NULL
that	NULL
these	NULL
antisera	NULL
quantitatively	NULL
abolished	NULL
the	NULL
PB1-binding	NULL
activity	NULL
demonstrated	NULL
that	NULL
this	NULL
complex	NULL
contains	NULL
Elf-1	NULL
or	NULL
a	NULL
highly	NULL
related	NULL
Ets	NULL
family	NULL
member	NULL
and	NULL
one	NULL
or	NULL
more	NULL
AP-1	NULL
family	NULL
members	NULL
.	NULL

To	NULL
more	NULL
precisely	NULL
determine	NULL
which	NULL
AP-1	NULL
family	NULL
members	NULL
were	NULL
contained	NULL
in	NULL
the	NULL
inducible	NULL
PBl-binding	NULL
complex	NULL
,	NULL
we	NULL
used	NULL
rabbit	NULL
antisera	NULL
specific	NULL
for	NULL
individual	NULL
Jun	NULL
and	NULL
Fos	NULL
proteins	NULL
in	NULL
EMSAs	NULL
with	NULL
the	NULL
PBI	NULL
oligonucleotide	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

Antisera	NULL
specific	NULL
for	NULL
c-Fos	NULL
and	NULL
JunB	NULL
both	NULL
abolished	NULL
most	NULL
of	NULL
the	NULL
inducible	NULL
PB1l-binding	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
,	NULL
a	NULL
«	NULL
-c-fos	NULL
and	NULL
«	NULL
-junB	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
antisera	NULL
specific	NULL
for	NULL
Fra-1	NULL
and	NULL
JunD	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
)	NULL
as	NULL
well	NULL
as	NULL
control	NULL
antisera	NULL
against	NULL
cardiac	NULL
troponin	NULL
C	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
,	NULL
a	NULL
«	NULL
-cTnC	NULL
)	NULL
,	NULL
cyclin	NULL
D1	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
,	NULL
«	NULL
-D1	NULL
)	NULL
,	NULL
c-Myc	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
,	NULL
a-c-myc	NULL
)	NULL
,	NULL
and	NULL
Ets-1	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
,	NULL
a	NULL
«	NULL
-ets-1	NULL
)	NULL
had	NULL
little	NULL
or	NULL
no	NULL
effect	NULL
on	NULL
this	NULL
binding	NULL
complex	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
suggested	NULL
that	NULL
the	NULL
major	NULL
inducible	NULL
PB1-binding	NULL
activity	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
contains	NULL
Elf-1	NULL
,	NULL
c-Fos	NULL
,	NULL
and	NULL
JunB	NULL
.	NULL

However	NULL
,	NULL
because	NULL
there	NULL
was	NULL
a	NULL
small	NULL
amount	NULL
of	NULL
residual	NULL
binding	NULL
activity	NULL
that	NULL
was	NULL
not	NULL
abolished	NULL
by	NULL
the	NULL
a-c-Fos	NULL
or	NULL
«	NULL
-JunB	NULL
anti-serum	NULL
,	NULL
we	NULL
can	NULL
not	NULL
rule	NULL
out	NULL
the	NULL
possibility	NULL
that	NULL
there	NULL
are	NULL
less	NULL
abundant	NULL
complexes	NULL
composed	NULL
of	NULL
Elf-1	NULL
and	NULL
other	NULL
AP-1	NULL
family	NULL
members	NULL
.	NULL

It	NULL
should	NULL
be	NULL
emphasized	NULL
that	NULL
previous	NULL
studies	NULL
have	NULL
demonstrated	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
antisera	NULL
used	NULL
in	NULL
these	NULL
experiments	NULL
(	NULL
2	NULL
,	NULL
17	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6B	NULL
,	NULL
these	NULL
antisera	NULL
did	NULL
not	NULL
inhibit	NULL
binding	NULL
of	NULL
CREB/ATF	NULL
proteins	NULL
to	NULL
the	NULL
control	NULL
Tal	NULL
oligonucleotide	NULL
(	NULL
14	NULL
)	NULL
from	NULL
the	NULL
human	NULL
T-cell	NULL
receptor	NULL
a	NULL
enhancer	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
is	NULL
unlikely	NULL
that	NULL
the	NULL
observed	NULL
activities	NULL
of	NULL
these	NULL
antisera	NULL
resulted	NULL
from	NULL
cross-reactivity	NULL
with	NULL
other	NULL
known	NULL
Ets	NULL
or	NULL
AP-1	NULL
family	NULL
members	NULL
or	NULL
from	NULL
nonspecific	NULL
effects	NULL
on	NULL
DNA	NULL
binding	NULL
.	NULL

However	NULL
,	NULL
we	NULL
can	NULL
not	NULL
rule	NULL
out	NULL
the	NULL
possibility	NULL
of	NULL
cross-reactivity	NULL
with	NULL
related	NULL
but	NULL
uncloned	NULL
Ets	NULL
or	NULL
AP-1	NULL
transcription	NULL
factors	NULL
.	NULL

DISCUSSION	NULL
The	NULL
GM-CSF	NULL
gene	NULL
has	NULL
been	NULL
studied	NULL
extensively	NULL
as	NULL
a	NULL
model	NULL
of	NULL
inducible	NULL
gene	NULL
expression	NULL
following	NULL
T-cell	NULL
activation	NULL
.	NULL

Unlike	NULL
the	NULL
case	NULL
for	NULL
other	NULL
lymphokine	NULL
genes	NULL
such	NULL
as	NULL
the	NULL
IL-2	NULL
gene	NULL
(	NULL
1	NULL
,	NULL
8	NULL
,	NULL
10	NULL
)	NULL
or	NULL
immediately-early	NULL
genes	NULL
such	NULL
as	NULL
c-myc	NULL
(	NULL
19	NULL
)	NULL
,	NULL
which	NULL
are	NULL
regulated	NULL
by	NULL
complex	NULL
multipartite	NULL
promoters	NULL
and	NULL
enhancers	NULL
,	NULL
inducible	NULL
GM-CSF	NULL
gene	NULL
expression	NULL
is	NULL
controlled	NULL
by	NULL
a	NULL
relatively	NULL
simple	NULL
57-bp	NULL
element	NULL
located	NULL
immediately	NULL
5	NULL
'	NULL
of	NULL
the	NULL
transcriptional	NULL
start	NULL
site	NULL
(	NULL
29	NULL
)	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
identified	NULL
a	NULL
19-bp	NULL
motif	NULL
within	NULL
this	NULL
region	NULL
which	NULL
binds	NULL
a	NULL
T-cell	NULL
nuclear	NULL
protein	NULL
complex	NULL
and	NULL
which	NULL
is	NULL
required	NULL
for	NULL
the	NULL
inducible	NULL
expression	NULL
of	NULL
the	NULL
intact	NULL
626-bp	NULL
promoter	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
28	NULL
,	NULL
29	NULL
)	NULL
.	NULL

This	NULL
motif	NULL
is	NULL
highly	NULL
conserved	NULL
in	NULL
both	NULL
the	NULL
human	NULL
and	NULL
murine	NULL
GM-CSF	NULL
genes	NULL
(	NULL
24	NULL
,	NULL
28	NULL
)	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
have	NULL
demonstrated	NULL
that	NULL
this	NULL
motif	NULL
,	NULL
which	NULL
we	NULL
have	NULL
called	NULL
PBI	NULL
,	NULL
binds	NULL
an	NULL
inducible	NULL
complex	NULL
from	NULL
activated	NULL
T-cell	NULL
nuclear	NULL
extracts	NULL
and	NULL
can	NULL
function	NULL
as	NULL
an	NULL
inducible	NULL
transcriptional	NULL
element	NULL
in	NULL
T	NULL
cells	NULL
when	NULL
multimerized	NULL
5	NULL
'	NULL
of	NULL
a	NULL
heterologous	NULL
promoter	NULL
.	NULL

More	NULL
importantly	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
PBI	NULL
is	NULL
composed	NULL
of	NULL
adjacent	NULL
Ets	NULL
and	NULL
AP-1	NULL
binding	NULL
sites	NULL
,	NULL
both	NULL
of	NULL
which	NULL
are	NULL
required	NULL
for	NULL
binding	NULL
of	NULL
the	NULL
inducible	NULL
T-cell	NULL
nuclear	NULL
complex	NULL
and	NULL
for	NULL
the	NULL
inducible	NULL
transcriptional	NULL
activity	NULL
of	NULL
PB1	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

Both	NULL
sites	NULL
are	NULL
also	NULL
required	NULL
for	NULL
the	NULL
inducible	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
intact	NULL
GM-CSF	NULL
promoter	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Using	NULL
antibodies	NULL
specific	NULL
for	NULL
individual	NULL
Ets	NULL
and	NULL
AP-1	NULL
family	NULL
members	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
major	NULL
inducible	NULL
PB1-binding	NULL
activity	NULL
present	NULL
in	NULL
activated	NULL
T-cell	NULL
nuclear	NULL
extracts	NULL
contains	NULL
Elf-1	NULL
,	NULL
c-Fos	NULL
,	NULL
and	NULL
JunB	NULL
.	NULL

Our	NULL
results	NULL
are	NULL
in	NULL
accord	NULL
with	NULL
the	NULL
previous	NULL
in	NULL
vitro	NULL
mutagenesis	NULL
experiments	NULL
of	NULL
Nimer	NULL
et	NULL
al	NULL
.	NULL

(	NULL
29	NULL
)	NULL
.	NULL

Although	NULL
these	NULL
previous	NULL
studies	NULL
did	NULL
not	NULL
identify	NULL
the	NULL
Ets	NULL
and	NULL
AP-1	NULL
binding	NULL
sites	NULL
,	NULL
they	NULL
did	NULL
show	NULL
that	NULL
mutations	NULL
or	NULL
deletion	NULL
of	NULL
1158	NULL
WANG	NULL
ET	NULL
AL	NULL
.	NULL

A	NULL
.	NULL

``	NULL
E	NULL
E	NULL
MS	NULL
y	NULL
a	NULL
|	NULL
6	NULL
=	NULL
/	NULL
>	NULL
a	NULL
``	NULL
45	NULL
e	NULL
:	NULL
ioo	NULL
id	NULL
$	NULL
$	NULL
4	NULL
4	NULL
%	NULL
5	NULL
Antiserum	NULL
:	NULL
'	NULL
83	NULL
~	NULL
5	NULL
Antiserum	NULL
:	NULL
'	NULL
8	NULL
8	NULL
s	NULL
s	NULL
s	NULL
s	NULL
%	NULL
4	NULL
>	NULL
.T	NULL
had	NULL
ah	NULL
ts	NULL
K6	NULL
:	NULL
%	NULL
Probe	NULL
:	NULL
-	NULL
GM-CSF	NULL
Tai	NULL
GM-CSF	NULL
a-c-myc	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BroL	NULL
.	NULL

C.	NULL
+A	NULL
2	NULL
w	NULL
(	NULL
3	NULL
)	NULL
'	NULL
e	NULL
'	NULL
e	NULL
o	NULL
m	NULL
-o	NULL
§	NULL
E	NULL
o	NULL
=	NULL
£	NULL
a	NULL
a	NULL
&	NULL
-E	NULL
Cate	NULL
P	NULL
w	NULL
144909	NULL
gziigao	NULL
Antiserum	NULL
:	NULL
«	NULL
++	NULL
8	NULL
8	NULL
8	NULL
s	NULL
s	NULL
s	NULL
8	NULL
10	NULL
s	NULL
s	NULL
s	NULL
s	NULL
s	NULL
8	NULL
s	NULL
d	NULL
s=	NULL
-m	NULL
2	NULL
ge	NULL
-	NULL
#	NULL
Probe	NULL
:	NULL
GM-CSF	NULL
Tal	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

The	NULL
inducible	NULL
PB1i-binding	NULL
activity	NULL
of	NULL
T	NULL
cells	NULL
contains	NULL
Elf-1	NULL
,	NULL
c-Fos	NULL
,	NULL
and	NULL
JunB	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Role	NULL
of	NULL
Elf-1	NULL
in	NULL
the	NULL
inducible	NULL
PB1-binding	NULL
activity	NULL
of	NULL
T	NULL
cells	NULL
.	NULL

Radiolabeled	NULL
probes	NULL
containing	NULL
the	NULL
PBI	NULL
sequence	NULL
from	NULL
the	NULL
murine	NULL
GM-CSF	NULL
promoter	NULL
(	NULL
bp	NULL
-33	NULL
to	NULL
-58	NULL
;	NULL
see	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
or	NULL
the	NULL
control	NULL
Tal	NULL
sequence	NULL
from	NULL
the	NULL
human	NULL
T-cell	NULL
receptor	NULL
a	NULL
enhancer	NULL
(	NULL
14	NULL
)	NULL
were	NULL
used	NULL
in	NULL
EMSAs	NULL
with	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
normal	NULL
human	NULL
T	NULL
cells	NULL
activated	NULL
for	NULL
8	NULL
h	NULL
with	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
.	NULL

Where	NULL
indicated	NULL
,	NULL
«	NULL
-Elf-1	NULL
antiserum	NULL
was	NULL
added	NULL
to	NULL
the	NULL
binding	NULL
reaction	NULL
mixtures	NULL
.	NULL

The	NULL
inducible	NULL
PBl-binding	NULL
activity	NULL
is	NULL
denoted	NULL
by	NULL
an	NULL
arrow	NULL
.	NULL

(	NULL
B	NULL
and	NULL
C	NULL
)	NULL
Role	NULL
of	NULL
AP-1	NULL
family	NULL
members	NULL
in	NULL
the	NULL
inducible	NULL
PB1-binding	NULL
activity	NULL
of	NULL
T	NULL
cells	NULL
.	NULL

EMSAs	NULL
using	NULL
the	NULL
radiolabeled	NULL
PB1	NULL
and	NULL
Tal	NULL
oligonucleotides	NULL
and	NULL
antisera	NULL
that	NULL
recognize	NULL
all	NULL
Jun	NULL
(	NULL
«	NULL
-jun	NULL
Family	NULL
)	NULL
or	NULL
all	NULL
Fos	NULL
(	NULL
a-fos	NULL
Family	NULL
)	NULL
family	NULL
members	NULL
or	NULL
specific	NULL
Fos	NULL
and	NULL
Jun	NULL
family	NULL
members	NULL
(	NULL
«	NULL
-c-fos	NULL
,	NULL
a-fra-1	NULL
,	NULL
«	NULL
-junB	NULL
,	NULL
and	NULL
«	NULL
-junD	NULL
)	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
above	NULL
.	NULL

The	NULL
a-cyclin	NULL
D1	NULL
(	NULL
«	NULL
-D1	NULL
)	NULL
,	NULL
a-c-Myc	NULL
,	NULL
o-Ets-1	NULL
,	NULL
and	NULL
a-cardiac	NULL
troponin	NULL
C	NULL
(	NULL
«	NULL
-cTnC	NULL
)	NULL
antisera	NULL
were	NULL
used	NULL
as	NULL
negative	NULL
controls	NULL
.	NULL

The	NULL
inducible	NULL
PB1l-binding	NULL
activity	NULL
is	NULL
denoted	NULL
by	NULL
an	NULL
arrow	NULL
.	NULL

PB1	NULL
nucleotides	NULL
included	NULL
in	NULL
the	NULL
Ets	NULL
and	NULL
AP-1	NULL
sites	NULL
(	NULL
as	NULL
identified	NULL
in	NULL
this	NULL
study	NULL
)	NULL
abolished	NULL
inducible	NULL
GM-CSF	NULL
promoter	NULL
activity	NULL
whereas	NULL
mutations	NULL
or	NULL
deletions	NULL
not	NULL
involving	NULL
the	NULL
Ets	NULL
and	NULL
AP-1	NULL
sites	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
promoter	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

Recent	NULL
studies	NULL
have	NULL
suggested	NULL
that	NULL
adjacent	NULL
Ets	NULL
and	NULL
AP-1	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
NFAT	NULL
element	NULL
of	NULL
the	NULL
IL-2	NULL
enhancer	NULL
also	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
regulating	NULL
inducible	NULL
IL-2	NULL
gene	NULL
expression	NULL
following	NULL
T-cell	NULL
activation	NULL
(	NULL
2	NULL
,	NULL
15	NULL
)	NULL
.	NULL

However	NULL
,	NULL
there	NULL
are	NULL
several	NULL
important	NULL
differences	NULL
in	NULL
the	NULL
structures	NULL
and	NULL
functions	NULL
of	NULL
the	NULL
NFAT	NULL
and	NULL
PB1	NULL
elements	NULL
.	NULL

First	NULL
,	NULL
the	NULL
spacings	NULL
of	NULL
the	NULL
Ets	NULL
and	NULL
AP-1	NULL
sites	NULL
are	NULL
different	NULL
(	NULL
directly	NULL
adjacent	NULL
in	NULL
PBI	NULL
and	NULL
separated	NULL
by	NULL
3	NULL
bp	NULL
in	NULL
NFAT	NULL
;	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Second	NULL
,	NULL
previous	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
the	NULL
major	NULL
NFAT-binding	NULL
complex	NULL
in	NULL
activated	NULL
human	NULL
T-cell	NULL
nuclear	NULL
extracts	NULL
contains	NULL
Fra-l	NULL
and	NULL
JunB	NULL
(	NULL
2	NULL
)	NULL
,	NULL
whereas	NULL
the	NULL
present	NULL
study	NULL
demonstrates	NULL
that	NULL
the	NULL
major	NULL
PB1-binding	NULL
activity	NULL
from	NULL
these	NULL
same	NULL
cells	NULL
contains	NULL
c-Fos	NULL
and	NULL
JunB	NULL
.	NULL

Of	NULL
note	NULL
,	NULL
the	NULL
two	NULL
studies	NULL
used	NULL
identical	NULL
antibody	NULL
preparations	NULL
,	NULL
and	NULL
therefore	NULL
it	NULL
is	NULL
unlikely	NULL
that	NULL
differences	NULL
in	NULL
the	NULL
antibody	NULL
preparations	NULL
could	NULL
account	NULL
for	NULL
these	NULL
results	NULL
.	NULL

Finally	NULL
,	NULL
although	NULL
we	NULL
have	NULL
shown	NULL
in	NULL
this	NULL
study	NULL
that	NULL
an	NULL
«	NULL
-Elf-1	NULL
antiserum	NULL
abolishes	NULL
the	NULL
major	NULL
inducible	NULL
PB1-binding	NULL
activity	NULL
from	NULL
activated	NULL
T-cell	NULL
nuclear	NULL
extracts	NULL
,	NULL
this	NULL
same	NULL
antiserum	NULL
has	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
NFAT-binding	NULL
complex	NULL
from	NULL
the	NULL
same	NULL
nuclear	NULL
extracts	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Given	NULL
these	NULL
data	NULL
,	NULL
it	NULL
seems	NULL
likely	NULL
that	NULL
the	NULL
NFAT	NULL
element	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
binds	NULL
a	NULL
nuclear	NULL
protein	NULL
complex	NULL
which	NULL
is	NULL
distinct	NULL
from	NULL
that	NULL
bound	NULL
by	NULL
the	NULL
PB1	NULL
element	NULL
of	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
.	NULL

Confirmation	NULL
of	NULL
this	NULL
model	NULL
awaits	NULL
the	NULL
precise	NULL
identification	NULL
of	NULL
the	NULL
transcription	NULL
factors	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
NFAT	NULL
site	NULL
.	NULL

The	NULL
finding	NULL
that	NULL
the	NULL
inducible	NULL
T-cell	NULL
PB1-binding	NULL
activity	NULL
is	NULL
composed	NULL
of	NULL
both	NULL
Ets	NULL
and	NULL
AP-1	NULL
family	NULL
members	NULL
suggests	NULL
that	NULL
multiple	NULL
mechanisms	NULL
may	NULL
regulate	NULL
the	NULL
binding	NULL
and	NULL
transcriptional	NULL
activity	NULL
of	NULL
this	NULL
complex	NULL
.	NULL

Thus	NULL
,	NULL
for	NULL
example	NULL
,	NULL
previous	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
both	NULL
c-Fos	NULL
and	NULL
JunB	NULL
are	NULL
transcriptionally	NULL
activated	NULL
during	NULL
T-cell	NULL
activation	NULL
(	NULL
7	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
dephosphorylation	NULL
of	NULL
Jun	NULL
family	NULL
members	NULL
may	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
their	NULL
activation	NULL
(	NULL
3	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
we	NULL
have	NULL
recently	NULL
shown	NULL
that	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
Elf-1	NULL
activity	NULL
is	NULL
regulated	NULL
by	NULL
binding	NULL
to	NULL
and	NULL
release	NULL
from	NULL
the	NULL
retinoblastoma	NULL
protein	NULL
and	NULL
that	NULL
this	NULL
binding	NULL
reaction	NULL
is	NULL
itself	NULL
regulated	NULL
by	NULL
activation-specific	NULL
phosphorylation	NULL
of	NULL
the	NULL
retinoblastoma	NULL
protein	NULL
following	NULL
T-cell	NULL
activation	NULL
(	NULL
32	NULL
)	NULL
.	NULL

These	NULL
results	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
observation	NULL
that	NULL
multiple	NULL
signaling	NULL
pathways	NULL
are	NULL
required	NULL
to	NULL
induce	NULL
lymphokine	NULL
gene	NULL
expression	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
4	NULL
,	NULL
8	NULL
,	NULL
10	NULL
)	NULL
.	NULL

They	NULL
also	NULL
suggest	NULL
that	NULL
simple	NULL
overexpression	NULL
of	NULL
a	NULL
single	NULL
Ets	NULL
or	NULL
AP-1	NULL
transcription	NULL
factor	NULL
will	NULL
be	NULL
insufficient	NULL
to	NULL
mimic	NULL
the	NULL
transcriptional	NULL
effects	NULL
of	NULL
T-cell	NULL
activation	NULL
on	NULL
GM-CSF	NULL
promoter	NULL
activity	NULL
.	NULL

Similarly	NULL
,	NULL
it	NULL
may	NULL
be	NULL
difficult	NULL
to	NULL
accurately	NULL
reconstruct	NULL
the	NULL
inducible	NULL
PB1-binding	NULL
activity	NULL
in	NULL
vitro	NULL
by	NULL
using	NULL
recombinant	NULL
proteins	NULL
.	NULL

Nevertheless	NULL
,	NULL
identification	NULL
of	NULL
the	NULL
components	NULL
of	NULL
the	NULL
inducible	NULL
PB1l-binding	NULL
activity	NULL
and	NULL
elucidation	NULL
of	NULL
the	NULL
functionally	NULL
important	NULL
protein-protein	NULL
interactions	NULL
and	NULL
posttranslational	NULL
modifications	NULL
of	NULL
the	NULL
complex	NULL
members	NULL
constitute	NULL
an	NULL
important	NULL
first	NULL
step	NULL
in	NULL
understanding	NULL
the	NULL
molecular	NULL
mechanisms	NULL
that	NULL
regulate	NULL
both	NULL
gene	NULL
expression	NULL
and	NULL
cell	NULL
cycle	NULL
progression	NULL
following	NULL
T-cell	NULL
activation	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
thank	NULL
Colette	NULL
McNicholas-Serwecinski	NULL
for	NULL
her	NULL
expert	NULL
secretarial	NULL
assistance	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
Public	NULL
Health	NULL
Service	NULL
grant	NULL
Al-29673	NULL
(	NULL
to	NULL
J.	NULL
M.	NULL
Leiden	NULL
)	NULL
from	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
.	NULL

L.	NULL
H.	NULL
Boise	NULL
is	NULL
a	NULL
fellow	NULL
of	NULL
the	NULL
Leukemia	NULL
Society	NULL
of	NULL
America	NULL
.	NULL

Vor	NULL
.	NULL

14	NULL
,	NULL
1994	NULL
ADDENDUM	NULL
IN	NULL
PROOF	NULL
Since	NULL
the	NULL
submission	NULL
of	NULL
the	NULL
manuscript	NULL
,	NULL
we	NULL
have	NULL
com	NULL
pared	NULL
the	NULL
signalling	NULL
requirements	NULL
of	NULL
the	NULL
PBI	NULL
and	NULL
NFAT	NULL
nuclear	NULL
protein	NULL
complexes	NULL
.	NULL

Unlike	NULL
NFAT	NULL
,	NULL
which	NULL
requires	NULL
stimulation	NULL
with	NULL
both	NULL
PMA	NULL
and	NULL
ionomycin	NULL
and	NULL
is	NULL
cyclosporin	NULL
A	NULL
sensitive	NULL
,	NULL
the	NULL
PBI	NULL
binding	NULL
activity	NULL
described	NULL
in	NULL
this	NULL
report	NULL
is	NULL
induced	NULL
by	NULL
treatment	NULL
of	NULL
normal	NULL
T	NULL
cells	NULL
with	NULL
PMA	NULL
alone	NULL
and	NULL
is	NULL
resistant	NULL
to	NULL
treatment	NULL
with	NULL
cyclosporin	NULL
A	NULL
.	NULL

These	NULL
differences	NULL
in	NULL
signalling	NULL
requirements	NULL
further	NULL
suggest	NULL
that	NULL
NFAT	NULL
and	NULL
PBI	NULL
are	NULL
composed	NULL
of	NULL
distinct	NULL
nuclear	NULL
proteins	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

REFERENCES	NULL
.	NULL

Arya	NULL
,	NULL
S.	NULL
K.	NULL
1988	NULL
.	NULL

Human	NULL
and	NULL
simian	NULL
immunodeficiency	NULL
retro-	NULL
virus	NULL
:	NULL
activation	NULL
and	NULL
differential	NULL
transactivation	NULL
of	NULL
gene	NULL
expres-sion	NULL
.	NULL

AIDS	NULL
Res	NULL
.	NULL

Hum	NULL
.	NULL

Retroviruses	NULL
4:175-186.	NULL
.	NULL

Boise	NULL
,	NULL
H.	NULL
L.	NULL
,	NULL
B.	NULL
Petryniak	NULL
,	NULL
X.	NULL
Mao	NULL
,	NULL
C.	NULL
H.	NULL
June	NULL
,	NULL
C.	NULL
Y.	NULL
Wang	NULL
,	NULL
T.	NULL
Lindsten	NULL
,	NULL
R.	NULL
Bravo	NULL
,	NULL
K.	NULL
Kovary	NULL
,	NULL
J.	NULL
M.	NULL
Leiden	NULL
,	NULL
and	NULL
C.	NULL
B.	NULL
Thompson	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
NFAT-1	NULL
DNA	NULL
binding	NULL
complex	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
contains	NULL
Fra-l	NULL
and	NULL
JunB	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:1911-1919.	NULL
.	NULL

Boyle	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
T.	NULL
Smeal	NULL
,	NULL
L.	NULL
H.	NULL
K.	NULL
Defize	NULL
,	NULL
P.	NULL
Angel	NULL
,	NULL
J.	NULL
R.	NULL
Woodgett	NULL
,	NULL
M.	NULL
Karin	NULL
,	NULL
and	NULL
T.	NULL
Hunter	NULL
.	NULL

1991	NULL
.	NULL

Activation	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
decreases	NULL
phosphorylation	NULL
of	NULL
c-jun	NULL
at	NULL
sites	NULL
that	NULL
negatively	NULL
regulate	NULL
its	NULL
DNA-binding	NULL
activity	NULL
.	NULL

Cell	NULL
64:573-584.	NULL
.	NULL

Cantrell	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
and	NULL
K.	NULL
A.	NULL
Smith	NULL
.	NULL

1984	NULL
.	NULL

The	NULL
interleukin-2	NULL
system	NULL
:	NULL
a	NULL
new	NULL
cell	NULL
growth	NULL
model	NULL
.	NULL

Science	NULL
224:1312-1316.	NULL
.	NULL

Chan	NULL
,	NULL
J.	NULL
Y.	NULL
,	NULL
D.	NULL
J.	NULL
Slamon	NULL
,	NULL
S.	NULL
D.	NULL
Nimer	NULL
,	NULL
D.	NULL
W.	NULL
Golde	NULL
,	NULL
and	NULL
J.	NULL
C.	NULL
Gasson	NULL
.	NULL

1986	NULL
.	NULL

Regulation	NULL
of	NULL
expression	NULL
of	NULL
human	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
GM-CSF	NULL
)	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
83:8669-8673.	NULL
.	NULL

Clark	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
and	NULL
R.	NULL
Kamen	NULL
.	NULL

1987	NULL
.	NULL

The	NULL
human	NULL
hematopoietic	NULL
colony-stimulating	NULL
factors	NULL
.	NULL

Science	NULL
236:1229-1237.	NULL
.	NULL

Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
1989	NULL
.	NULL

Contingent	NULL
genetic	NULL
regulatory	NULL
events	NULL
in	NULL
T	NULL
lymphocyte	NULL
activation	NULL
.	NULL

Science	NULL
243:355-361.	NULL
.	NULL

Durand	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
J.	NULL
P.	NULL
Shaw	NULL
,	NULL
M.	NULL
R.	NULL
Bush	NULL
,	NULL
R.	NULL
E.	NULL
Replogle	NULL
,	NULL
R.	NULL
Belagaje	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
.	NULL

1988	NULL
.	NULL

Characterization	NULL
of	NULL
antigen	NULL
response	NULL
elements	NULL
within	NULL
the	NULL
interleukin-2	NULL
enhancer	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8:1715-1724.	NULL
.	NULL

Fleischmann	NULL
,	NULL
J.	NULL
,	NULL
D.	NULL
W.	NULL
Golde	NULL
,	NULL
R.	NULL
H.	NULL
Weisbart	NULL
,	NULL
and	NULL
J.	NULL
C.	NULL
Gasson	NULL
.	NULL

1986	NULL
.	NULL

Granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
enhances	NULL
phagocytosis	NULL
of	NULL
bacteria	NULL
by	NULL
human	NULL
neutrophils	NULL
.	NULL

Blood	NULL
©708-711	NULL
.	NULL

Fujita	NULL
,	NULL
T.	NULL
,	NULL
H.	NULL
Shibuya	NULL
,	NULL
T.	NULL
Ohashi	NULL
,	NULL
K.	NULL
Yamanishi	NULL
,	NULL
and	NULL
T.	NULL
Taniguchi	NULL
.	NULL

1986	NULL
.	NULL

Regulation	NULL
of	NULL
human	NULL
interleukin-2	NULL
gene	NULL
:	NULL
functional	NULL
DNA	NULL
sequence	NULL
in	NULL
the	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
for	NULL
the	NULL
gene	NULL
expression	NULL
in	NULL
activated	NULL
T	NULL
lymphocytes	NULL
.	NULL

Cell	NULL
46:401-407	NULL
.	NULL

Gasson	NULL
,	NULL
J.	NULL
C.	NULL
1991	NULL
.	NULL

Molecular	NULL
physiology	NULL
of	NULL
granulocyte-mac-rophage-colony-stimulating	NULL
factors	NULL
.	NULL

Blood	NULL
77:1131-1145	NULL
.	NULL

Gasson	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
R.	NULL
H.	NULL
Weisbart	NULL
,	NULL
S.	NULL
E.	NULL
Kaufman	NULL
,	NULL
S.	NULL
C.	NULL
Clark	NULL
,	NULL
R.	NULL
M.	NULL
Hewick	NULL
,	NULL
G.	NULL
G.	NULL
Wong	NULL
,	NULL
and	NULL
D.	NULL
W.	NULL
Golde	NULL
.	NULL

1984	NULL
.	NULL

Purified	NULL
human	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
:	NULL
direct	NULL
action	NULL
on	NULL
neutrophils	NULL
.	NULL

Science	NULL
226:1339-1342	NULL
.	NULL

Grabstein	NULL
,	NULL
K.	NULL
H.	NULL
,	NULL
D.	NULL
L.	NULL
Urdal	NULL
,	NULL
R.	NULL
J.	NULL
Tushinski	NULL
,	NULL
D.	NULL
Y.	NULL
Mochizuki	NULL
,	NULL
V.	NULL
L.	NULL
Price	NULL
,	NULL
M.	NULL
A.	NULL
Cantrell	NULL
,	NULL
S.	NULL
Gillis	NULL
,	NULL
and	NULL
P.	NULL
J.	NULL
Conlon	NULL
.	NULL

1986	NULL
.	NULL

Introduction	NULL
of	NULL
macrophage	NULL
tumoricidal	NULL
activity	NULL
by	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
.	NULL

Science	NULL
232:506-508	NULL
.	NULL

Ho	NULL
,	NULL
I.-C.	NULL
,	NULL
L.-H.	NULL
Yang	NULL
,	NULL
G.	NULL
Morle	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Leiden	NULL
.	NULL

1989	NULL
.	NULL

A	NULL
T-cell-specific	NULL
transcription	NULL
enhancer	NULL
element	NULL
3	NULL
'	NULL
of	NULL
Ca	NULL
in	NULL
the	NULL
human	NULL
T-cell	NULL
receptor	NULL
a	NULL
locus	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:6714-6718	NULL
.	NULL

Jain	NULL
,	NULL
J.	NULL
,	NULL
P.	NULL
G.	NULL
McCaffrey	NULL
,	NULL
V.	NULL
E.	NULL
Valge-Archer	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1992	NULL
.	NULL

Nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
contains	NULL
fos	NULL
and	NULL
jun	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
356:801-804	NULL
.	NULL

Kovary	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
R.	NULL
Bravo	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
Jun	NULL
and	NULL
Fos	NULL
protein	NULL
families	NULL
are	NULL
both	NULL
required	NULL
for	NULL
cell	NULL
cycle	NULL
progression	NULL
in	NULL
fibro-blasts	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11:4466-4472	NULL
.	NULL

Kovary	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
R.	NULL
Bravo	NULL
.	NULL

1992	NULL
.	NULL

Existence	NULL
of	NULL
different	NULL
Jun	NULL
and	NULL
Fos	NULL
proteins	NULL
during	NULL
G	NULL
,	NULL
-to-G	NULL
,	NULL
transition	NULL
and	NULL
during	NULL
exponential	NULL
growth	NULL
in	NULL
mouse	NULL
fibroblasts	NULL
:	NULL
differential	NULL
role	NULL
of	NULL
Fos	NULL
proteins	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:5015-5023	NULL
.	NULL

TRANSCRIPTIONAL	NULL
ACTIVATION	NULL
OF	NULL
THE	NULL
GM-CSF	NULL
PROMOTER	NULL
IN	NULL
T	NULL
CELLS	NULL
18	NULL
.	NULL

19	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

24	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

1159	NULL
Leiden	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
C.	NULL
Y.	NULL
Wang	NULL
,	NULL
B.	NULL
Petryniak	NULL
,	NULL
D.	NULL
M.	NULL
Markovitz	NULL
,	NULL
G.	NULL
J.	NULL
Nabel	NULL
,	NULL
and	NULL
C.	NULL
B.	NULL
Thompson	NULL
.	NULL

1992	NULL
.	NULL

A	NULL
novel	NULL
Ets-related	NULL
transcription	NULL
factors	NULL
,	NULL
Elf-1	NULL
,	NULL
binds	NULL
to	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
2	NULL
regulatory	NULL
elements	NULL
that	NULL
are	NULL
required	NULL
for	NULL
inducible	NULL
trans	NULL
activation	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

66:5890-5897	NULL
.	NULL

Lindsten	NULL
,	NULL
T.	NULL
C.	NULL
,	NULL
C.	NULL
H.	NULL
June	NULL
,	NULL
and	NULL
C.	NULL
B.	NULL
Thompson	NULL
.	NULL

1988	NULL
.	NULL

Multiple	NULL
mechanisms	NULL
regulating	NULL
c-myc	NULL
gene	NULL
expression	NULL
during	NULL
normal	NULL
T-cell	NULL
activation	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

7:2787-2794.	NULL
.	NULL

Markovitz	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
M.	NULL
Hannibal	NULL
,	NULL
V.	NULL
L.	NULL
Perez	NULL
,	NULL
C.	NULL
Gauntt	NULL
,	NULL
T.	NULL
M.	NULL
Folks	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1990	NULL
.	NULL

Differential	NULL
regulation	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
(	NULL
HIVs	NULL
)	NULL
:	NULL
a	NULL
specific	NULL
regulatory	NULL
element	NULL
in	NULL
HIV-2	NULL
responds	NULL
to	NULL
stimulation	NULL
of	NULL
the	NULL
T-cell	NULL
antigen	NULL
receptor	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87:9098-9102	NULL
.	NULL

Matsushime	NULL
,	NULL
H.	NULL
,	NULL
M.	NULL
E.	NULL
Ewen	NULL
,	NULL
D.	NULL
K.	NULL
Strom	NULL
,	NULL
J.	NULL
Kato	NULL
,	NULL
S.	NULL
K.	NULL
Hanks	NULL
,	NULL
M.	NULL
F.	NULL
Roussel	NULL
,	NULL
and	NULL
C.	NULL
J.	NULL
Sherr	NULL
.	NULL

1992	NULL
.	NULL

Identification	NULL
and	NULL
properties	NULL
of	NULL
an	NULL
atypical	NULL
catalytic	NULL
subunit	NULL
(	NULL
p34	NULL
``	NULL
**/cdk4	NULL
)	NULL
for	NULL
mammalian	NULL
D	NULL
type	NULL
G1	NULL
cyclins	NULL
.	NULL

Cell	NULL
71	NULL
;	NULL
323-334	NULL
.	NULL

McCune	NULL
,	NULL
J.	NULL
M.	NULL
1991	NULL
.	NULL

HIV-1	NULL
:	NULL
the	NULL
infective	NULL
process	NULL
in	NULL
vivo	NULL
.	NULL

Cell	NULL
64:351-363.	NULL
.	NULL

Metcalf	NULL
,	NULL
D.	NULL
1985	NULL
.	NULL

The	NULL
granulocyte-macrophage	NULL
colony-stimulat-	NULL
ing	NULL
factor	NULL
.	NULL

Science	NULL
229:16-22	NULL
.	NULL

Miyatake	NULL
,	NULL
S.	NULL
,	NULL
T.	NULL
Otsuka	NULL
,	NULL
F.	NULL
Lee	NULL
,	NULL
and	NULL
K.	NULL
Arai	NULL
.	NULL

1985	NULL
.	NULL

Structure	NULL
of	NULL
the	NULL
chromosomal	NULL
gene	NULL
for	NULL
granulocyte-macrophage	NULL
colony	NULL
stimulating	NULL
factor	NULL
:	NULL
comparison	NULL
of	NULL
the	NULL
mouse	NULL
and	NULL
human	NULL
genes	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

4:2561-2568.	NULL
.	NULL

Miyatake	NULL
,	NULL
S.	NULL
,	NULL
J.	NULL
Shlomai	NULL
,	NULL
K.	NULL
Arai	NULL
,	NULL
and	NULL
N.	NULL
Arai	NULL
.	NULL

1991	NULL
.	NULL

Charac-	NULL
terization	NULL
of	NULL
mouse	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
GM-CSF	NULL
)	NULL
gene	NULL
promoter	NULL
:	NULL
nuclear	NULL
factors	NULL
that	NULL
interact	NULL
with	NULL
an	NULL
element	NULL
shared	NULL
by	NULL
three	NULL
lymphokine	NULL
genes-those	NULL
for	NULL
GM-CSF	NULL
,	NULL
interleukin-4	NULL
(	NULL
IL-4	NULL
)	NULL
,	NULL
and	NULL
IL-5	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11	NULL
:	NULL
5894-5901	NULL
.	NULL

Nabel	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1987	NULL
.	NULL

A	NULL
inducible	NULL
transcription	NULL
factor	NULL
activates	NULL
expression	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
326:711-713	NULL
.	NULL

Niemeyer	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
C.	NULL
A.	NULL
Sieff	NULL
,	NULL
B.	NULL
Mathey-Prevot	NULL
,	NULL
J	NULL
.	NULL

Z.	NULL
Wimperis	NULL
,	NULL
B.	NULL
E.	NULL
Bierer	NULL
,	NULL
S.	NULL
C.	NULL
Clark	NULL
,	NULL
and	NULL
D.	NULL
G.	NULL
Nathan	NULL
.	NULL

1989	NULL
.	NULL

Expression	NULL
of	NULL
human	NULL
interleukin-3	NULL
(	NULL
multi-CSF	NULL
)	NULL
is	NULL
restricted	NULL
to	NULL
human	NULL
lymphocytes	NULL
and	NULL
T	NULL
cell	NULL
tumor	NULL
cell	NULL
lines	NULL
.	NULL

Blood	NULL
73:945-961.	NULL
.	NULL

Nimer	NULL
,	NULL
S.	NULL
,	NULL
D.	NULL
A.	NULL
Elaine	NULL
,	NULL
E.	NULL
A.	NULL
Morita	NULL
,	NULL
M.	NULL
J.	NULL
Martis	NULL
,	NULL
and	NULL
W.	NULL
Wachsman	NULL
.	NULL

1988	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
human	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
region	NULL
by	NULL
genetic	NULL
analy-sis	NULL
:	NULL
correlation	NULL
with	NULL
DNase	NULL
I	NULL
footprinting	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8:1979-1984	NULL
.	NULL

Nimer	NULL
,	NULL
S.	NULL
,	NULL
J.	NULL
Farser	NULL
,	NULL
J.	NULL
Richards	NULL
,	NULL
M.	NULL
Lynch	NULL
,	NULL
and	NULL
J.	NULL
Gasson	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
repeat	NULL
sequence	NULL
CATT	NULL
(	NULL
A/T	NULL
)	NULL
is	NULL
required	NULL
for	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
promoter	NULL
activity	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:6084-6088	NULL
.	NULL

Shomaker	NULL
,	NULL
S.	NULL
G.	NULL
,	NULL
R.	NULL
Hromas	NULL
,	NULL
and	NULL
K.	NULL
Kaushansky	NULL
,	NULL
.	NULL

1990	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
of	NULL
interleukin-3	NULL
gene	NULL
expression	NULL
in	NULL
T	NULL
lymphocytes	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87:9650-9654	NULL
.	NULL

Thompson	NULL
,	NULL
C.	NULL
B.	NULL
,	NULL
C.	NULL
Y.	NULL
Wang	NULL
,	NULL
I.	NULL
Ho	NULL
,	NULL
P.	NULL
R.	NULL
Bohjanen	NULL
,	NULL
B.	NULL
Petryniak	NULL
,	NULL
C.	NULL
H.	NULL
June	NULL
,	NULL
S.	NULL
Miesfeldt	NULL
,	NULL
L.	NULL
Zhang	NULL
,	NULL
G.	NULL
J.	NULL
Nabel	NULL
,	NULL
B.	NULL
Karpinski	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Leiden	NULL
.	NULL

1992.	NULL
cis-acting	NULL
sequences	NULL
required	NULL
for	NULL
inducible	NULL
interleukin-2	NULL
enhancer	NULL
function	NULL
bind	NULL
a	NULL
novel	NULL
Ets-related	NULL
protein	NULL
,	NULL
Elf-1	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:1043-1053	NULL
.	NULL

Wang	NULL
,	NULL
C.	NULL
Y.	NULL
,	NULL
C.	NULL
B.	NULL
Thompson	NULL
,	NULL
B.	NULL
Petriniak	NULL
,	NULL
W.	NULL
G.	NULL
Kaelin	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Leiden	NULL
.	NULL

1993	NULL
.	NULL

Regulation	NULL
of	NULL
an	NULL
Ets-related	NULL
transcription	NULL
factor	NULL
,	NULL
Elf-1	NULL
,	NULL
by	NULL
binding	NULL
to	NULL
the	NULL
retinblastoma	NULL
protein	NULL
.	NULL

Science	NULL
260:1330-1335	NULL
.	NULL

Weisbart	NULL
,	NULL
R.	NULL
H.	NULL
,	NULL
D.	NULL
W.	NULL
Golde	NULL
,	NULL
S.	NULL
C.	NULL
Clark	NULL
,	NULL
G.	NULL
G.	NULL
Wong	NULL
,	NULL
and	NULL
J.	NULL
C.	NULL
Gasson	NULL
.	NULL

1985	NULL
.	NULL

Human	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
is	NULL
a	NULL
neutrophil	NULL
activator	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
314:361-363	NULL
.	NULL

Weisbart	NULL
,	NULL
R.	NULL
H.	NULL
,	NULL
L.	NULL
Kwan	NULL
,	NULL
D.	NULL
W.	NULL
Golde	NULL
,	NULL
and	NULL
J.	NULL
C.	NULL
Gasson	NULL
.	NULL

1987	NULL
.	NULL

Human	NULL
GM-CSF	NULL
primes	NULL
neutrophils	NULL
for	NULL
enhanced	NULL
oxidative	NULL
metabolism	NULL
in	NULL
response	NULL
to	NULL
the	NULL
major	NULL
physiological	NULL
chemoattrac-tants	NULL
.	NULL

Blood	NULL
69:18-21	NULL
.	NULL

Wong	NULL
,	NULL
G.	NULL
G.	NULL
,	NULL
J.	NULL
S.	NULL
Witek	NULL
,	NULL
P.	NULL
A.	NULL
Temple	NULL
,	NULL
K.	NULL
M.	NULL
Wilkens	NULL
,	NULL
D.	NULL
P.	NULL
Luxenberg	NULL
,	NULL
S.	NULL
S.	NULL
Jones	NULL
,	NULL
E.	NULL
L.	NULL
Brown	NULL
,	NULL
R.	NULL
M.	NULL
Kay	NULL
,	NULL
E.	NULL
C.	NULL
Orr	NULL
,	NULL
C.	NULL
Shoemaker	NULL
,	NULL
D.	NULL
W.	NULL
Golde	NULL
,	NULL
R.	NULL
J.	NULL
Kaufman	NULL
,	NULL
R.	NULL
M.	NULL
Hewick	NULL
,	NULL
E.	NULL
A.	NULL
Wang	NULL
,	NULL
and	NULL
S.	NULL
C.	NULL
Clark	NULL
.	NULL

1985	NULL
.	NULL

Human	NULL
GM-CSF	NULL
:	NULL
molecular	NULL
cloning	NULL
of	NULL
the	NULL
complementary	NULL
DNA	NULL
and	NULL
purification	NULL
of	NULL
the	NULL
natural	NULL
and	NULL
recombinant	NULL
proteins	NULL
.	NULL

Science	NULL
228:810-815	NULL
.	NULL

